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Respondent/Cross-Appellant MRI Associates, LLP ("MRIA"), 1 hereby submits its reply 
brief in support of its cross-appeal. 
I. ARGUMENT 
As indicated in MRIA's opening brief, if SARMC's2 request for a new trial is denied on 
appeal, the Court need not address MRIA 's cross-appeal. MRIA only seeks to appeal the 
following rulings if the Court determines that a new trial is warranted. In the event SARMC is 
granted a new trial, the trial court's denial ofMRIA's motion for leave to seek punitive damages 
should be reversed as there is overwhelming evidence that (1) SARMC acted in extreme 
deviation from reasonable standards of conduct when it willfully and deliberately competed with 
its partners in MRIA and that (2) SARMC did so with full knowledge that its conduct would 
result in the destruction ofMRIA's business. Additionally, in the event SARMC is granted a 
new trial, the trial court's grant of summary judgment on MRIA's antitrust claims should also be 
reversed because MRIA sufficiently asserted an antitrust injury and showed that SARMC and 
Intermountain Imaging ("!MI") had market power. 
A. The Trial Court Abused Its Discretion When It Denied MRIA's Request for Leave 
to Seek Punitive Damages. 
The overwhelming evidence clearly and convincingly demonstrates that SARMC, while 
still a partner in MRIA, deliberately competed with MRIA in violation of SARMC's contractual 
and fiduciary duties. SARMC did so with willful disregard for the consequences of its wrongful 
1 References to MRIA also include its business arms: MRI Limited Partnership aka MRI Center 
of Idaho ("MRICI") and MRI Mobile ("MRIM"). 
2 References to SARMC include both Saint Alphonsus Diversified Care, Inc. and Saint 
Alphonsus Regional Medical Center. 
conduct. As a result, MRIA's business was destroyed. (Trial Ex. 4519.) The evidence further 
demonstrates that the trial court's failure to instruct on punitive damages "was so contrary to the 
facts of the case as to amount to an abuse of discretion under the deferential standard." General 
Auto Parts Co., Inc. v. Genuine Parts Co., 132 Idaho 849,825,979 P.2d 1207, 1210 (1999). 
I. Punitive Damages Are Appropriate in a Commercial Context. 
SARMC suggests that punitive damages are not warranted because "wrongful 
dissociation is no different than a breach of contract, which does not give rise to punitive 
damages." (SARMC's Reply Brief at 42.) SARMC, however, is wrong. As this Court held in 
Myers v. Workmen's Auto Ins. Co., 140 Idaho 495, 95 P.3d 977 (2004), "[i)t is not the nature of 
the case, whether tort or contract, that controls the issue of punitive damages." What controls is 
whether SARMC's conduct was oppressive, fraudulent, malicious or outrageous. I. C. § 6-
1604(1 ). 
According to this Court, J.C.§ 6-1604(1) "requires an intersection of two factors: a bad 
act and a bad state of mind." Linscott v. Ranier Nat'! Life Ins. Co., 100 Idaho 854,858,606 P.2d 
958, 962 (l 980). The Court recognized that in the past it had used various terms to describe the 
"bad act" requirement such as "deceit," acting "to violate another's legal right," acting "for 
purpose of injuring plaintiff," "to oppress," acting "(in) disregard ... of the known property 
rights," and "fraud." Id The Court also recognized it had used the following terms to describe a 
"bad state of mind": "deliberate," and "gross negligence." Id; see also Cheney v. Palos Verde 
Inv. Corp., I 04 Idaho 897, 905, 665 P.2d 661, 669 (1983) (holding the bad state of mind can be 
shown if the act was simply "deliberate or willful"). The Court then noted "[i]n two cases 
2 
involving breach of a contract, this court even held that it was proper to award punitive damages 
when there was 'other sufficient reason."' Linscott, 100 Idaho at 858,606 P.2d at 962; see also 
Rockefeller v. Grabow,136 Idaho 637, 646-47, 39 P.3d 577, 586-87 (2001) (recognizing a 
punitive damages amendment is proper where there is evidence of violations of fiduciary duties); 
Cuddy Mountain Concrete Inc. v. Citadel Constr., Inc., 121 Idaho 220,229, 824 P.2d 151, 160 
(Idaho Ct. App. 1992) (recognizing punitive damages are proper when a party breaches it duty to 
act in good faith). 
Thus, a breach of contract may give rise to punitive damages where the conduct "show[ s] 
a lack of professional regard for the consequences of the breach of the contractual agreement." 
Cuddy Mountain, 121 Idaho at 229,824 P.2d at 160. Stated simply, punitive damages are proper 
when the conduct is willful or deliberate regardless of the type of claim. Cheney v. Palos Verde 
Inv. Corp., 104 Idaho 897,905,665 P.2d 661,669 (1983). Here, SARMC's actions were willful, 
deliberate, and much more egregious than a mere breach of contract. SARMC, in willful 
violation of its fiduciary and contractual duties and with conscious disregard for the 
consequences of its actions, competed with its partners in MRIA and took other actions which 
caused the financial ruin of MRIA. 
2. The Standard of Review for Determining Whether the Trial Court Abused 
Its Discretion is Substantial Evidence. 
Although SARMC is correct that the decision of whether to submit the issue of punitive 
damages to the jury is reviewed under abuse of discretion, "[t]his Court has interpreted the abuse 
of discretion standard in the context of punitive damages as whether there was substantial 
3 
evidence to support submitting the issue to the jury." Highland Enterprises Inc. v. Baker, 133 
Idaho 330, 348, 986 P.2d 1011, 1014 (1999) (citing Student Loan Fund of Idaho Inc. v. Duerner, 
131 Idaho 45, 52, 951 P.2d 1272, 1279 (1998) ("On appeal, we will not disturb the trial court's 
decision unless there was an abuse of discretion, which has been interpreted within the punitive 
damages context to mean whether there was substantial evidence to support submission of the 
issue to the jury.")); see also Rockefeller v. Grabow,136 Idaho 637,647, 39 P.3d 577, 587 (2001) 
("In determining whether the trial court abused its discretion this Court will consider whether 
substantial evidence supports submitting the issue [of punitive damages] to the jury."). Thus, 
even though the standard is deferential, the law requires the trial court's decision to be reversed 
if substantial evidence supported submitting the issue to the jury. 
3. The Issue of Punitive Damages Should Have Been Submitted to the Jury 
Because There Was Substantial Evidence that SARMC Committed a "Bad 
Act" with a "Bad State of Mind." 
In this case, the issue of punitive damages should have been submitted to the jury because 
there was clear and convincing (not just substantial) evidence that SARMC "deliberately" or as 
the trial court described, "blatantly" (the bad state of mind) competed with its partner MRIA and 
"violated [MRIA's] legal right[s]" (the bad act). (TR Vol. III at 4471 :9-17.) The evidence 
demonstrates that SARMC's conduct, which the Jury found to be intentional and in bad faith, 
was an extreme deviation from the reasonable standard of care and was taken without 
professional regard for the consequences of the conduct. (R., Ex. 48 at 1117-28, attached as Ex. 
A to Reply Appendix (Reply App.") attached hereto.) The evidence further demonstrates that 
SARMC's wrongful conduct was more egregious than merely breaching a contract, as SARMC 
4 
erroneously contends. 
a. SARMC Willfully and Knowingly Breached Its Fiduciary Duties to Its 
Partners and Breached the MRIA Partnership Agreement. 
As fully set forth in prior briefing, SARMC wrongfully withdrew from MRIA on April 1, 
2004. (R. Vol. II at 388-96, Vol. III at 538-46.) Moreover, it is not as ifSARMC withdrew for a 
benign purpose. Instead, it withdrew because it had joined MRIA's competitor, !Ml. (Trial Ex. 
4226.) Furthermore, at the time of its wrongful withdrawal from MRIA, SARMC knew that by 
dissociating for purposes of competing with MRIA it would be violating the express terms of the 
MRIA Partnership Agreement. This knowledge is evidenced by the clear language in the MRIA 
Partnership Agreement (including the withdrawal and noncompete provisions), the analysis of 
SARMC's consulting firms and the admonitions from SARMC's attorneys. 
For example, SARMC was warned by PriceWaterhouseCoopers in January 2000 (over 
• four years before its wrongful withdrawal) that the MRIA Partnership Agreement restricted the 
right of SARMC to withdraw from MRIA. (Trial Ex. 4138 at 16 attached as Reply App. Ex. B; 
R. Vol. II at 388-96, Vol. III at 538-46.) SARMC also was reminded by its consultant Shattuck 
Hammond that "SARMC ha[ d] been advised by counsel that this option [ withdrawal from 
MRIA J would likely engender litigation with MRIA .... Givens Pursley believes that that there 
would likely be litigation as to whether the termination was wrongful .... " (Trial Ex. 4239 at 2, 
11.) The evidence established that SARMC fully understood the legal implications of these 
warnings. (TR. Vol. II at 1950:10-15; TR Vol. III at 3594:9-13; 3595:23-3596:6.) 
SARMC also knew its involvement in !MI, while still a partner in MRIA, violated 
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SARMC's fiduciary duties to MRIA. Indeed, SARMCs CEO testified that she understood that 
(1) "a partner must not help a third party compete with the partnership", (2) "a partner must not 
compete with the partnership", (3) "one of a partner's responsibilities to his other partners is not 
to exploit his position", ( 4) "a partner must not profit at the partnership's expense", and (5) "a 
partner must not exploit information obtained through his position as a partner." (TR Vol. II at 
1686:7-13, 23-25; 1684:2-5; 1680:1-4; 1685:12-15; 1682:6-18.) Despite this knowledge, 
SARMC, under the leadership of its CEO, not only helped a third-party compete with the 
partnership, but it also later joined that third-party competitor, competed with the partnership 
itself, and ultimately profited at the partnership's expense. Likewise, SARMC's Chief Operating 
Officer, Cindy Schamp, admitted that in 2001 she learned from SARMC's consultants that · 
competing with MRIA through IMI could be a breach of SARMC's fiduciary duties. (TR Vol. 
III at 3593:21-3594:16.) Similarly, SARMC understood (by no later than 2001) that SARMC's 
conduct created "a risk of St. Alphonsus breaching its fiduciary responsibility to [MRJCI and 
MRI A1obile}." (Trial Ex. 4239 at 11 (emphasis added).) This evidence clearly establishes the 
"bad state of mind" requirement. 
b. SARMC Also Wilfully Supported and Joined a Competitor While StUJ 
a Partner in MRIA with Knowledge of, and Disregard for, the 
· Consequences to MRIA. 
In addition to wrongfully withdrawing, SARMC's willful bad acts, while still a partner in 
MR.IA, include: 
• Helping IMI establish itself as a MRIA's competitor; 
6 
• Usurping MRIA's opp01tunity to partner with GSR/IMI3; 
• Formally partnering with IMI and providing IMI with significant financial support; 
• Actively joint marketing with IMI to shift referrals from MRIA to IMI; 
• Making IMI its outpatient facility; 
• Condoning conduct by GSR which caused referrals to shift from MRIA to IMI; 
• Refusing to allow MRIA to contract with radiologists other than GSR; 
• Bringjng IMI onto SARMC's campus virtually next~door to MRICI; and 
• Issuing a written mandate to all of its employees, including referring physicians, directing 
that all patients be sent to the IMI magnet rather than to MRJCI. 
This conduct, which is described in more detail below, clearly and convincingly demonstrates 
that SARMC deliberately competed with MRIA in violation of SARMC's contractual and 
fiduciary duties. SARMC knew or should have known that its conduct would destroy MRIA, 
both in terms of lost revenues and the substantial fees and costs that MRIA would have to incur 
in order to enforce its legal rights under the partnership agreement. (TR Vol. II at 1690:20-
1691 :5; 1871:8-9.) SARMC's knowledge of, and professional disregard for, the consequences of 
its wrongful conduct is aptly summarized by SARMC's CEO's testimony: "I was a partner with 
3 References to "GSR" include St. Alphonsus Radiology Group n/k/a Gem State Radiology. 
GSR was the exclusive reader of SARMC's radiologic images including MRICI's images. (TR 
Vol. II at 1446:10-1447:2. 
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a competitor. I was supporting myself." (TR Vol. II at 1871 :8-9.)4 
i. SARMC Supported the Establishment ofMRIA's Competitor, 
IMI. 
While still a partner in MRIA, SARMC knowingly helped IMI become a lethal 
competitor of MRIA by investing money and resources into the establishment of IMI. 
SARMC's support during IMI's initial start-up included:(!) providing the backing necessary for 
!MI to obtain funding; (2) providing SARMC's case volume, database, technical component 
charges, staffing costs, and other operational data for IMI' s use in its business plan; (3) linking 
!MI to the intranet between SARMC and its physician network; (4) supporting Karen Noyes, 
assistant director of the SARMC radiology department, in joining IM! as executive director; and 
(5) converting SARMC to the same digital radiography system as IM!. (Trial Ex. 4095 attached 
as Reply App. Ex. C; see also Trial Ex. 4074 (showing in February 1999, SARMC was working 
on funding for IM!)). In fact, without SARMC's help, IMI likely would not have obtained 
financing. (Trial Ex. 545 at 3, attached as Reply App. Ex. D ("[F]inancing [for IM!) was 
contingent on a partnership with the hospital." (emphasis added)). 
ii. SARMC's IT Support Provided IMI with a Tremendous 
Competitive Advantage. 
Although still a partner in MRIA, SARMC partnered with GSR, from IMI' s inception, to 
convert IM!' s technology from film to digital imaging. SARMC helped bring this "digital 
4 The evidence set forth in the proceeding sections was in large part the same evidence submitted 
with MRIA's motion for leave to seek punitive damages, which motion was renewed at the close 
of the evidence. (See R., Ex. 47 at 1-20; R. Ex. 48 at ,J,J 17-28; R., Exs. 68 & 69.) 
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revolution to IMI" by initially investing several hundred thousand dollars in IMI's IT system. 
(TR Vol. II at 1505:10-1507:10; Trial Ex. 4095, attached as Reply App. Ex. C.) The investment 
by SARMC in "dark fiber" connectivity to IM!, alone, was $780,000. (Trial Ex. 423 lat 3 
attached as Reply App. Ex. E; TR Vol. II at 1509:6-13.) SARMC also provided technical 
resources to !MI, including the formation of a joint IT committee with IM!, which MRIA was 
not allowed to join. (Id. at 1619:12-1621:20; 2437:18-2439:9.) Consequently, this support 
provided IMI with an enormous competitive advantage over MRICI. (Ex. 4107, attached as 
Reply App. Ex. G; TR Vol. IL 1618:22-1619:3, 1497:15-1502:24.) 
iii. SARMC Usurped MRIA's Opportunity to Partner with 
GSR/IMI. 
As set forth in MRIA's opening brief, MRIA had an opportunity to partner with GSR in 
IM[ rather than compete with IM!. In that regard, in June 1999, MRIA asked SARMC's CEO, 
Sandra Bruce, to help MRIA close the deal with GSR. (TR Vol. II at 1164:2-1165: 16, 1759:24-
1760: 14.) Although Bruce agreed to help, instead of negotiating on MRIA's behalf, she put the 
MRIA negotiations on hold and then offered GSR a better deal: a 50% interest in an MR imaging 
business rather than the 9% (one-eleventh) interest offered by MRIA. (Id. at I 165:8-1166:16, 
1760:3-1761:18, 1769:7-10, 1788:19-1790:15, 1786:15-19, 2043:24-2044:5, 2371:4-10, 3702:9-
11, 4171:13-21; Trial Ex. 4101; Trial Ex. 4191 at 3.) It is not surprising that GSR accepted 
SARMC's better offer and partnered with SARMC instead ofMRIA. (Trial Ex. 4226). By this 
conduct, SARMC, while still a partner in MRIA, deliberately took for itself an opportunity 
9 
belonging to MRIA. 5 
iv. SARMC Formally Partnered with IMI and Provided IMI with 
Significant Financial Support. 
In June, 200 l, while still a partner in MRIA, SARMC formally joined as a partner with 
GSR in !MI and received a 50 percent interest in IM!. (Trial Ex. 4226 at 6.) At that time, 
SARMC gave !MI $546,146 and asswned almost $1.5 million ofIMI's debt. (TR Vol. II at 
1557:4-1558:2; 1622:22-1623:8.) This financial support was in addition to SARMC's financial 
investment in IM!' s IT systems. 
v. SARMC Actively Competed With Its Partners in MRIA by 
Joint Marketing with IMI to Shift Referrals from MRIA to 
IMI. 
Even though IMI was MRIA's main competitor and even though SARMC as a partner in 
MRIA owed MRIA a duty not to compete, SARMC actively worked with IMI to obtain a 
combined market share for magnetic resonance imaging, in direct competition with MRIA. (Trial 
Ex. 4248 attached as Reply App. Ex. F; TR Vol. II at 1643:7-13, 1646:1-7; TR Vol. III at 
4169: 10-17.) SARMC and IMI jointly marketed by television, radio, newspapers, letters to 
referring physicians and physician-to-physician office visits. (Trial Exs. 4248 & 4107 attached as 
Reply App. Exs. F and G; TR Vol. II at 1643 :23-1644:22.) This joint marketing caused 
confusion among the referring doctors as to which imaging center was affiliated with SARMC. 
(Id at 2420: 11-16; 2428:21-2429:6.) As a result, marketing for MRIA became difficult. (Id.) 
5 SARMC, while still a partner in MRIA, also usurped MRIA's opportunity to open an imaging 
center in Meridian, Idaho by helping open !MI Meridian (AKA !MI West). (Trial Exs. 4156, 
4115, 4211 & 4275; TR Vol. II at 1590:11-23; 1613:5-12; 1615:20-23.) 
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vi. SARMC Ensured that IMI was Viewed by the Referring 
Physicians as SARMC's Imaging Center. 
In addition to joint marketing with !MI, SARMC, while still a partner in MRIA, made 
IM! SARMC's outpatient facility which ensured that IM! (not MRIA) would be viewed by 
referring physicians as SARMC's imaging center. (Id at l582:10-1583:24.) Because this 
development was communicated to the referring doctor community (the source ofMRIA's 
business), MRIA lost scans because referring physicians became "used to sending patients to 
IM!, not just for CT, but for MRI as well." (Id at 1583:17-24.) 
vii. SARMC Allowed Its New Partner GSR to Engage in Conduct 
Intended to Shift Referrals from MRIA to IMI. 
Shortly after IMI opened in late 1999, GSR began to reduce its services to MRICI and 
otherwise began engaging in conduct detrimental to MRICI. (TR Vol. II at 1176: 19-1180:7 .) 
Consequently, MRIA requested SARMC to intervene and return radiologist service to its 
previous, professional level: 
The time has come for SARMC to insist on and provide full, supportive 
radiologic coverage of the lab at historical levels of professionalism and service .. 
. . [Such coverage] cannot be allowed to be withdrawn simply because the 
radiologists of the lab are now also its competitors. The highest standard of care 
for patients is essential and includes having radiologists on site to supervise 
studies as needed. We now view as a necessity SARMC's providing the lab with 
full, supportive, traditional radiologist coverage or permitting the MRI Center of 
Idaho to contract directly with radiologists as a fiduciary responsibility of 
SARMC to its other general and limited partners. 
(Trial Ex. 4137 at 2 attached as Reply App. Ex. H; see also TR Vol. II at 1176:19-1180:7.) 
SARMC, although still a partner in MRIA, never responded to MRIA's request. (TR Vol. II at 
1182:9-14.) Indeed, as SARMC's relationship with GSR in IM! intensified, the GSR 
l l 
radiologists became bolder in their unfair tactics by (1) unilaterally reducing weekday hours at 
MRI CI, while increasing IMI's hours of service for its MRI modality, and (2) cancelling all 
weekend support to MRI CI, except for emergency cases. (See, Trial Ex. 4277 & 4309 at 3-4, 2 
attached as Reply App. Ex. I and J; TR Vol. II at 1217: 11-1219:8; 1653:23-1655:25; 1924:3-20; 
2195 :2-7; 2392:5-24) Consequently, MRIA lost a substantial portion of its scan volume to IMI. 
(TR Vol. II at 2633:8-2634:4; 2742:13-2743:6; 2796:15-2797:1; 2877:25-2878:3; Trial Ex. 4247 
at 13, Trial Ex. 4519 attached as Ex. D to the Appendix to MRIA's opening brief.) Again, 
SARMC refused to help because by supporting IMI, it was supporting itself. (TR Vol. II at 
1871 :8-9.) 
viii. SARMC Refused to Allow MRIA to Contract with Other 
Radiologists. 
After usurping MRIA's opportunity to partner with GSR in IMI, SARMC then helped 
further destroy MRIA's business by forcing MRIA to have its images read by its competitor, 
GSR (one of the owners of IMI), thereby allowing MRIA's competitor to interface with MRIA's 
referring physicians. (Trial Ex. 4137 at 2, attached as Reply Ex. H; TR Vol. II at 1488:8-1489:3.) 
When MRIA requested SARMC's permission to "contract directly with radiologists" who were 
not MRIA's competitors, SARMC, although still a partner in MRIA, ignored such requests. (TR 
Vol. II at 1175:23-1176:ll, 1182:9-14; Trial Ex. 4137,attached as Reply App. Ex. H.) 
Essentially, SARMC insisted on using the fox to guard the henhouse. 
ix. SARMC Moved an IMI Magnet Onto Its Campus and 
Ordered SARMC Physicians to Use IMI Instead ofMRIA. 
SARMC delivered a one-two death blow by opening an IMI magnet on its campus next 
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to MRI CI and by issuing a written mandate to all of its employees, including referring 
physicians, directing that all patients be sent to the IMI magnet rather than to MRICI. (TR Vol. 
II at 2173:21-24; Trial Ex. 4377, attached as Reply App. Ex. K.) This mandate along with 
SARMC's other misconduct, reduced the MRICI business ofMRIA to an almost bankrupt 
company. (Trial Ex. 4519, attached as Ex. D to the Appendix to MRIA's opening brief.) 
4. SARMC's "Scorched Earth Scenario." 
Among the evidence before the trial court when ruling on MRIA 's motion was the 
statement by SARMC's consultant that "SARMC has referred to [withdrawal from MRIA] as 
their 'scorched earth scenario."' (Trial Ex. 4239 at 11; R. Vol. IX at2116-18). This "scorched 
earth scenario," as demonstrated by the evidence, was the strategy that SARMC ultimately 
pursued in its relationship with MRIA. The fact that SARMC referred to the strategy as the 
"scorched earth scenario" is very telling concerning SARMC's state of mind. It establishes that 
SARMC's withdrawal and competition with its partners was done willfully, deliberately, 
maliciously and with the intent to harm MRIA. 6 
5. SARMC's Conduct Constitutes an Extreme Deviation from Normal 
Standards of Conduct. 
SARMC erroneously asserts that there was no evidence that SARMC's conduct 
constituted an extreme deviation from reasonable standards of conduct. Contrary to SARMC's 
assertion, the evidence set forth above and set forth more fully in MRIA's opening brief, 
6 That the trial court went out of its way to prevent the jury from being prejudiced is 
demonstrated by the trial court's decision, after it ruled upon MRIA's motion, to exclude from 
the jury any reference to "scorched earth." This fact belies SARMC's arguments that the trial 
court allowed MRIA to prejudice the jury. 
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demonstrates that SARMC took numerous actions that were extreme deviations from reasonable 
standards of conduct. The evidence shows that in addition to its wrongful withdrawal, SARMC 
undertook a course of conduct intended to inflict the greatest harm possible on MRIA. Indeed, it 
is axiomatic that it was an extreme deviation from reasonable standards of conduct among 
partners for a partner like SARMC to breach its contractual and fiduciary duties by competing 
with its fellow partners and seeking to run those fellow partners out of business for the purpose 
of reaping higher profits for itself. That, however, is exactly what SARMC did in the instant 
case. 
Furthermore, it must be noted that SARMC objected to MRIA's expert, Professor 
Branson, on the grounds that whether SARMC's conduct was an extreme deviation from 
reasonable standards of care was not a proper subject for expert testimony. (R., Ex. 73 at 9.) 
The trial court agreed and excluded Professor Branson's testimony. (R. Vol. VII at 1317-1323.) 
Nevertheless, the trial court had that testimony when it ruled on MRIA's motion. (R., Ex. 48.) 
Professor Branson, after reviewing the evidence of SARMC's shocking conduct, 
concluded that SARMC's misconduct constituted an extreme deviation from normal standards of 
conduct followed by partners, and that the actions of SARMC were taken with a professional 
disregard for their consequences to MRIA. (Id. at,, 17-28.) Specifically Professor Branson 
opined that: 
• SARMC knowingly engaged in conduct that was an extreme deviation 
from the standards of conduct partners ·owe in a partnership in that it 
repeatedly served the best interests of competitors (IMI, ICR, and 
SARG/GSR) rather than the best interests of the MRIA Partnership, of 
which it was a partner. 
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• SARMC engaged in a further extreme departure from the applicable 
partnership standard of conduct by its wrongful dissociation, without any 
colorable grounds therefor, and despite warnings from authoritative 
sources (PricewaterhouseCoopers, Shattuck Hammond Partners) that such 
a dissociation would be wrongful. 
• SARMC further departed from the applicable partnership standard of 
conduct by efforts to dissociate from the partnership in bad faith, 
apparently attempting to inflict harm on the MRJA partnership and the 
other partners therein by, inter alia, wrongfully demanding immediate 
payment for its partnership interest; preparing a portable MRI unit pad in 
the SARMC parking lot; threatening to restrict MRICI's access to the 
SARMC DR server and P ACS systems, which required MRI CI to build its 
own P ACS/RIS system; condoning or facilitating the curtailment of 
services and availability of SARG/GSR radiologists at MRI CI; 
simultaneously condoning or facilitating the expansion of services and 
availability of SARG/GSR physicians at the competing IMI facilities; and 
in general pursuing what it termed a r1scorched earth" approach to its 
attempted dissociation. 
• In addition to having departed from the standards of conduct wh1ch govern 
partners in a partnership, SARMC violated the express provisions of the 
MRIA Partnership Agreement by its attempted withdrawal from the JVlRIA 
Partnership without any colorable grounds, or any grounds at all, therefor. 
• SARMC violated the express provisions of the MRIA Partnership Agreement by 
competing, alone and through its affiliate, IMI, with the MRIA Partnership, in 
violation of the express covenant not to compete contained in the .MR.IA 
Partnership Agreement. 
• SARMC usurped a partnership opportunity, and aided and abetted the usurpation 
ofa partnership opportunity by another, in providing infonnation technology, 
telecommunications, records storage and retrieval, human resources, experienced 
personnel and other services, without distinction between MRI and non-MRI 
lines of business, to the IMI 9th and Myrtle diagnostic imaging facility in Boise, 
Idaho. 
• Similarly, SARMC usurped a second partnership opportunity, and aided and 
abetted the USl.Upation of a partnership opportunity by another, in providing 
information technology, telecommunications, records storage and retrieval, 
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human resources, experienced personnel and other services, without distinction 
between MRI and non-MRI-lines of business to the diagnostic imaging facility in 
Meridian, Idaho. 
(Id. at ,r,r 17-23.) Professor Branson further found that SARMC engaged in a ''radical and 
extreme departure from the standards applicable to dealings between or among partners when it 
made affirmative misrepresentations, told half-truths, or dissembled, to its fellow partners, either 
in response to inquiries from its partners, or on its own volition." (Id. at ,r 27.) Professor 
Branson then testified to the following as examples of such misrepresentations: 
• SARMC [represented it] would not support MRI operations at IMI LLC 
when in fact it did, over a period of several years. 
• SARMC [represented it] had no plans for participation in any Meridian, 
Idaho diagnostic imaging facility, when it in fact did have plans. 
• SARMC not only failed to disclose but actively concealed its commitment 
to pursue a Meridian, Idaho facility in connection with IMI. 
• Dissembled regarding the undisclosed service by key SARMC employees 
on the boards of managers, or of partners, respectively, of the competing 
entitles, IMI and MRIA, in the latter of which SARMC was a partner. 
• Failed to disclose to its partners the provision of confidential MRJA 
financial infonnation to potential third party investors or putative lenders to 
SARMC. 
• Misrepresented the affiliate status of IMI once SARMC had become a 
signatory to the IMI Operating Agreement, with 3 of 6 SARMC managers 
on the MI Board of Managers. 
• Did not accurately disclose the extent of its $2.1 million investment and the 
use (commingling) of the investment in support ofIMl's MRI as weH as its 
non-MRl lines of business. 
(Id.) This testimony supports the strong evidence that MRIA presented which demonstrated that 
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SARMC's conduct constituted an extreme deviation from reasonable standards of care. 
6. SARMC's Conduct was at Least as Egregious as Conduct Found by this 
Court to be Sufficient to Support a Claim for Punitive Damages. 
Despite SARMC 's protestation that its conduct was nothing more than a breach of 
contract, the totality of the evidence demonstrates that its conduct was much more egregious. 
Indeed, the conduct was at least as egregious as conduct found by this Court to be sufficient to 
support a claim for punitive damages. For example, in Rockefeller v. Grabow, this Court 
sustained an award of punitive damages in a commercial dispute where a realtor was "working 
actively against [his clients') interests" and favored one client to the detriment of another 
"thereby violating his fiduciary duty to the Grabows." I 36 Idaho 637, 647, 39 P.3d 577, 587 
(2001 ). Here, SARMC' s conduct was more egregious in that SARMC not only favored IMI over 
its partners in MRIA, it actively conspired to compete against, and ultimately destroy, MRIA 
while still a partner in MRIA. 
In General Auto Parts Co., Inc. v. Genuine Parts Co.,132 Idaho 849,854,979 P.2d 1207, 
1212 (1999), this Court discussed with approval two Court of Appeals cases affirming punitive 
damage awards under less egregious facts. The first case, Cuddy Mountain Concrete Inc. v. 
Citadel Cons tr., Inc., 121 Idaho 220 824 P .2d 151 (Idaho Ct. App. 1992) involved a breach of 
contract claim between a general contractor (Citadel) and a subcontractor (Cuddy Mountain). 
Citadel terminated the contract without giving Cuddy Mountain the required seven-day written 
notice. The Court of Appeals "determined that the following behavior by Citadel constituted 
oppressive conduct sufficient to support an award of punitive damages: (I) the evidence showed 
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that Citadel's decision to terminate 'was conceived in frustration and consummated in anger' and 
there was no evidence that Citadel gave any thought to the consequences of its decision; (2) the 
termination in fact caused financial hardship to Cuddy Mountain; (3) Citadel refused to pay the 
balance Cuddy Mountain demanded for the work it had performed; and (4) following 
termination, Citadel altered certain daily reports which had been prepared prior to the 
termination." General Auto Parts,132 Idaho at 854, 979 P.2d at 1212 (citing Cuddy Mountain, 
121 Idaho at 227-28, 824 P.2d at 158-59.) Here, SARMC's actions were more egregious than 
Citadel's. Whereas Citadel's actions were consummated in anger, SARMC's actions were cool, 
deliberate and premeditated. Whereas Citadel's actions were taken without regard to the 
consequences, SARMC conducted itself with full knowledge of, but with intentional and willful 
disregard for, the consequences of its actions, taking a "scorched earth" approach. 
The second case the Court discussed with approval is Davis v. Gage, I 06 Idaho 735, 682 
P .2d 1282 (Ct.App.1984). In Davis, the Gages sold real property to the Davises so that Davises 
could build a restaurant/tavern. Id. at 737-38, 682 P.2d at 1284-85. As part of the sale, the 
Gages agreed not to open a competing business on nearby property owned by the Gages. Id 
The Gages, in violation of the noncompete agreement, opened a competing business and tore 
down the Davises' billboard advertising their restaurant. Id At trial, the Davises were awarded 
nominal damages and punitive damages. The Gage's appealed arguing, among other things, that 
punitive damages may not be awarded in a breach of contract case. Id. at 739; 682 P .2d at 1286. 
The Court of Appeals rejected the argument holding that: 
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The district court stated that it could "imagine no clearer case of a 
violation of the intent expressed by the noncompetition clause in 
the original agreement." Nor can we. The covenant not to compete 
was clear and unambiguous. The Gages' conduct was, according to 
the district court, "willful, wanton, malicious and the proper 
subject for punitive damages." 
Id. Likewise, in the instant case, the covenant not to compete was clear and unambiguous and 
SARMC's conduct was willful and deliberate. However, the relationship between SARMC and 
MRIA was far closer than the relationship between the Gage's and the Davises. When compared 
to the Gages conduct against a purchaser, SARMC's conduct was more egregious as it was 
aimed at the partners to whom SARMC owed a duty of trust and fidelity. Despite such duty, 
SARMC took conscious acts aimed at promoting, establishing and operating a competing 
business in violation of the partnership's non-compete agreement and aimed at destroying MRIA 
or otherwise hindering MRIA' s ability to compete. 
Thus, SARMC's conduct clearly justifies submitting the issue of punitive damages to the 
jury as that conduct was at least as, if not more, egregious than conduct found by this Court to be 
sufficient to support a claim for punitive damages. SARMC deliberately and with conscious 
disregard for the consequences of its actions, competed with its partners in MRIA and took other 
actions which caused the destruction ofMRIA's business. 
7. The Court Did NQ! Exercise Reasoned Judgment When It Refused to Submit 
the Issue of Punitive Damages to the Jury. 
Because there was substantial evidence that SARMC willfully and deliberately violated 
its contractual and fiduciary duties with conscious disregard for the legal right of MRIA, the trial 
court did not exercise reasoned judgment when it refused to submit the issue of punitive damages 
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to the jury. Student Loan Fund of Idaho Inc. v. Duerner, 131 Idaho 45, 52, 951 P.2d 1272, 1279 
(l 998). Additionally, the trial court's contradictory statements concerning the evidence 
demonstrate that the trial court failed to exercise reason when it refused to submit the issue. It is 
true that when MRIA renewed its motion at the close of the evidence, the trial court denied the 
motion stating that MRIA did not prove the necessary conduct with clear and convincing 
· evidence. (TR Vol. III at 4261: 18-4262:2.) That decision, however, is directly contradicted by 
the trial court's comment on the evidence at the hearing on SARMC's motion for a new trial. 
But this court listened to overwhelming evidence that the executive 
management team at Saint Alphonsus really blatantly ignored the 
partnership rights of a partner. I think the evidence that came in 
was clear and convincing. I think that's just what was out there 
through the discovery process over many years. It was 
demonstrated to this jury that Saint Alphonsus chose to compete 
directly/indirectly with a partner. And the jury so found. 
(Id. at 4471 :9-17 (emphasis added).) This finding that MRIA proved with "clear and 
convincing" evidence that SARMC "blatantly ignored the partnership rights of partner" by 
competing with MRIA supports an award of punitive damages. Furthermore, this finding, which 
came after further reflection upon the evidence by the trial court, is consistent with the 
substantial evidence produced at trial as illustrated above and proves that the trial court failed to 
exercise reasoned judgment when it refused to submit the issue of punitive damages to the jury. 
Consequently, the trial court's refusal to submit the issue to the jury should be reversed in the 
event the Court grants SARMC a new trial. 
B. The Trial Court Erred in Dismissing MRIA's Antitrust Claims. 
The trial court erred when it granted summary judgment in favor of SARMC dismissing 
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MRIA's antitrust counterclaims. (See R. Vol. V, at 905-946; R. Vol. XI at 2077-81). As 
previously discussed in MRIA's opening brief, the trial court wrongly held that MRIA lacked 
standing because it had not suffered an "antitrust injury." This Court should also reject 
SARMC's alternative theories that SARMC's actions increased competition, or that a jury would 
be unable to conclude that SARMC had the ability to achieve monopoly power. 
1. Standard of Review. 
On appeal from the grant of a motion for summary judgment, the Court employs the same , 
standard used by the district judge originally ruling on the motion. Jntermountain Eye and Laser 
Centers, P.L.L.C. v. Miller, 142 Idaho 218,222, 127 P.3d 121, 125 (2005). Summary judgment 
is proper only where there are no genuine issues of material fact and the moving party is entitled 
to judgment as a matter of law. Fenn v. Noah, 142 Idaho 775, 778, 133 P.3d 1240, 1243 (2006); 
l.R,C.P. 56( c ). The facts must be liberally construed and all inferences will be drawn in favor of 
the non-moving party. Fenn, 142 Idaho at 778, 133 P.3d at 1243. The Court reviews the record 
before the district court, including the pleadings, depositions, admissions and affidavits, if any, to 
determine de novo whether, after construing the facts in the light most favorable to the 
nonmoving party, there exists any genuine issues of material fact. Woodland Furniture, LLC v. 
Larsen, 142 Idaho 140,143,124 P.3d 1016, 1019 (2005). 
2. Under Idaho Law, MRIA Did Not Need to Show Harm to Competition as a 
Whole or Monopoly Power to Assert Its Antitrust Claims. 
As noted in MRIA's opening brief, Idaho law, as set forth in Twin Falls Farm & City 
Distributing, Inc. v. D & B Supply Co, 96 Idaho 351,528 P.2d 1286 (1974), does not require a 
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showing of"market injury" and "market power" to sustain an antitrust claim. In, Twin Falls, the 
Court ultimately held that a fiduciary's breach ofloyalty, combined with a third-party's 
knowledge of and assistance in that breach, constituted anticompetitive conduct in violation of 
Idaho's antitrust laws. The Court did not require a showing of market injury or market power. 
The facts of Twin Falls are similar to the facts of the instant case. In Twin Falls, the 
manager of the plaintiffs retail store pursued an opportunity to join the defendant's competing 
store. Id. at 353,528 P.2d at 1288. During this time, the defendant knew that the manager 
worked for the plaintiffs store. Id. The manager assisted the defendant with a lease 
opportunity, knowing this would give the defendant a competitive advantage over the plaintiff. 
Id. The manager was hired to manage the defendant's store, and they worked together to take 
over the plaintiffs prime location. Id. As a result, the plaintiff lost its location, a portion of its 
customer base, and some of its employees. Id. at 353-354, 528 P.2d at 1288-1289. Overturning 
the district court's summary judgment in favor of the defendant, the Idaho Supreme Court 
determined that the manager breached his fiduciary duty to the plaintiff and that this breach, with 
the defendant's knowledge and assistance, amounted to anticompetitive conduct in violation of 
Idaho's antitrust laws. Id. at 356-360, 528 P.2d at 1291-1295. 
As with the manager and defendant in Twin Falls, SARMC's conduct also constitutes a 
violation ofldaho's antitrust laws. Like the manager in Twin Falls, SARMC breached its 
fiduciary duties. (R. Vol. XII at 2296.) Like the manager and defendant in Twin Falls, SARMC 
and IM! worked together to create a competing entity while disparaging MRIA, (R. Conf. Ex. l 
at 7, Exhibit PP thereto), and providing advantages to the competing entity, IM!. (R. Conf. Ex. l 
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at 3, Exhibit Hand at 7, Exhibit 00 thereto.) Consistent with the rationale outlined in Twin 
Falls, this conduct not only constitutes a breach of loyalty/fiduciary duty on SARMC's part, but 
also constitutes a violation of antitrust laws by both SARMC and !MI. 
In Twin Falls this Court did not require the plaintiff to show evidence of a market-wide 
injury, as required by the district court in the instant case. Instead, this Court found it sufficient 
that the plaintiff was injured by the conspiracy to drive the plaintiff out of business. Twin Falls. 
at 359,528 P.2d at 1294. Here, there was ample evidence presented to the trial court that 
SARMC and !MI conspired to drive MRIA out of business. Such evidence is sufficient to 
sustain an antitrust claim under this Court's decision in Twin Falls. 
Notably, SARMC did not even address Twin Falls in its brief. Instead, SARMC focused 
on federal cases and the requirements of federal law. SARMC apparently hopes that this Court 
will ignore its prior holding in Twin Falls. The decision in Twin Falls, however, cannot be 
ignored because it remains controlling law in Idaho and because MRIA's claim was made under 
Idaho, not federal, law. (R., Vol.Vat 905-946.) Therefore, because MRIA's antitrust claims 
were sufficient under Twin Falls, the trial court erred when it granted summary judgment against 
MRIA on those claims. 
3. Even ifMRIA Was Required to Show Harm to Competition as Whole, 
MRIA Satisfied that Requirement. 
Even if the requirements of federal case law are applicable, MRIA has satisfied those 
requirements. According to federal case law, a private plaintiff has standing to bring an antitrust 
action if, among other things, it asserts an antitrust injury. Balak/aw v. Lovell, 14 F.3d 793, 
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797 (2nd Cir. 1994 ). The purpose of antitrust laws is to protect the public by keeping the 
channels of competition free. Pennsylvania Water & Power Co, v. Fed Power Com 'n., 193 F.2d 
230 (D.C. Cir. 1952). Therefore, it has been said that a plaintiff shows an "antitrust injury" when 
it shows harm to competition as a whole. See New York Medscan LLC v. New York Univ. Sch. of 
Med, 430 F. Supp. 2d 140, 146 (S.D.N.Y. 2006). A plaintiff shows such harm to competition by 
alleging adverse effects on the price, quality, or output of the relevant good or service. See id. 
Contrary to the district court's holding and SARMC's argument, MRIA presented ample 
evidence establishing such adverse effects on the local MRI services market. 
MRIA alleged facts showing broadly that SARMC's tactics had market-wide effects 
beyond merely impacting MRIA's own profits. Compare with Brunswick Corp. v. Pueblo 
Bowl-O-Mat, Inc., 429 U.S. 477, 97 S.Ct. 690 (1977). These tactics, which are more fully 
delineated in MRIA's opening brief(Respondent's Brief at 72-74, n. 47), include making 
misleading reports to the referring physician community, providing lower levels of service to 
MRIA patients, receiving higher prices for comparable goods and services, and directing patients 
away from MRIA's facilities. MRIA outlined a number of ways that SARMC's tactics caused 
an antitrust injury, including reducing patient care (R. Vol.Vat 905-46 at iii! 40, 68, 127); 
increasing price (id. at iii! 66, 127), and decreasing the output of medical imaging (id at ii 72). 
MRIA also submitted an affidavit and report from its economic expert, Edward Whitelaw, 
stating a number of ways in which SARMC's actions increased price and harmed competition in 
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the market.7 (R., Ex. 144). Whitelaw opined in a similar manner in his deposition. (R., Ex. 104 
at Ex. D, p. 50: 14-23; see also R., Ex. I ! 0 at Ex. A, p. 2-14; R., Ex. 143 at 2, Ex. A thereto at 
12).8 Construing these facts in favor ofMRIA, as the Court must, this evidence is more than 
sufficient to raise a genuine issue of material fact that an antitrust injury had occurred. Contrary 
to SARMC's arguments, these facts reflect an injury to the competitive market, not merely to 
MRIA as a competitor in the market. 
SARMC nevertheless argues that the Court should affirm the summary judgment because 
its activities increased competition by causing IM! to join the market. (Cross-Respondent's Brief 
at 45-47). The facts and evidence submitted to the trial court establishes that the opposite 
actually occurred. As discussed above, MRIA demonstrated that SARMC' s activities damaged, 
rather than increased, competition in the market. Moreover, SARMC's conduct was "without 
7 To the extent that the district court reasoned that Whitelaw's report did not sufficiently show a 
"market wide injury," the court itself hampered MRIA's ability to prove market-wide injury 
when it ruled that MRI providers in the relevant market would not be requJred to produce any 
records of MRI scans. (R. Vol. III at 557-60). That decision prevented MRIA from presenting 
relevant evidence concerning harm in the market. (See R., Ex. I 10, Exhibit A at 2-3). The trial 
court cannot complain about Jack of evidence when a decision of the trial court prevented MRIA 
from obtaining that evidence. See Vaught v. Dairyland Ins. Co., 131 Idaho 357,363,956 P.2d 
674, 680 (1998) (recognizing that it may be an abuse discretion to deny the discovery of critical 
information unavailable from another source). 
8 The fact that SARMC's expert disputed Whitelaw's opinion does not support the trial court's 
decision to grant summary judgment because summary judgment is inappropriate when 
reasonable minds come to different conclusions. Carl H Christensen Family Trust v. 
Christensen, 133 Idaho 866,870,993 P.2d l 197, 1201 (1999) ("If reasonable minds might come 
to different conclusions, summary judgment is inappropriate."); Watts v. Lynn, 125 Idaho 341, 
346 870 P.2d 1300, 1305 (1994) (recognizing prior decisions holding that summary judgment is 
inappropriate where conflicting testimony from experts is presented). 
25 
legitimate business purpose" for it was only to eliminate competition, and not to increase 
competition. Gen. Indus. Corp. v. Hartz Mountain Corp., 810 F.2d 795,804 (8th Cir. 1987). As 
the Supreme Court has said, "[i]f a firm has been 'attempting to exclude rivals on some basis 
other than efficiency,' it is fair to characterize its behavior as predatory." Aspen Skiing Co. v. 
Aspen Highlands Skiing Corp. 472 U.S. 585,605, 105 S.Ct. 2847, 2859 (!985) (citation 
omitted). 
Gen. Indus. Corp., 8IO F.2d 795, is illustrative. In that case, the plaintiff had been a non-
exclusive distributor of the defendant's products for a number of years. Id. at 798. In order to 
meet a request made by one of the plaintiffs retail customers, the plaintiff began to distribute 
competing products as well. Id. at 798-99. These products were of comparable quality for a 
lower price. Id. at 798. As a result, the defendant began enforcing a contract provision limiting 
credit to the plaintiff, despite years of waiving the provision. Id. at 798-99. The defendant also 
began supplying orders that were short-shipped or otherwise inaccurate, causing friction between 
the plaintiff and its retail customers. Id at 799. Ultimately, the defendant terminated the 
contract and began heavily advertising on behalf of the plaintiffs closest competitor. Id. The 
Court held that these actions were not reasonably gauged to promote competition based upon the 
quality of the products or the efficiency of the companies, but instead that the defendant 
"invoked its considerable market power to cause superior competing products to fail to reach 
retail shelves, preempting any opportunity for the consumer to make a real choice." Id. at 804. 
That is precisely what happened in this case. SARMC's tactics, including making 
misleading reports to the referring physician community, (It Conf. Ex. 1 at 7, Exhibit PP 
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thereto), providing lower levels of service to MRI Center patients, (R. Conf. Ex. I at 7, Exhibit 
00 thereto), directing patients away from MRIA's facilities, (R. Conf. Ex. I at 7, Exhibit LL and 
Ex. 143 at 2, Exhibit B thereto), and preventing SARMC affiliated doctors from having the 
ability to digitally review MRIA reports while allowing such doctors access to IMI reports (Tr. 
Vol. II, 2437: I 0- 2439: 17); were designed to prevent MRIA's comparable lower-priced services 
from reaching the public and preempting any opportunity for the consumer to make a real 
choice.9 The facts and evidence establish that SARMC's conduct with respect to IMI was 
predatory and not for a legitimate business purpose to increase competition, as SARMC would 
have this Court believe. 
4. MRIA Has Not Conceded Its Antitrust Argument. 
To the extent that SARMC argues that MRIA is precluded from making an antitrust 
argument because it "concedes" that competition was the actionable conduct (Cross-
Respondent's Brief at 46-47), the argument is erroneous and misplaced. SARMC cites to a 
footnote in MRIA's opening brief where MRIA discussed SARMC's irrelevant citations to 
antitrust cases in a discussion ofMRIA damages for SARMC's breaches of contract and 
fiduciary duties. (Respondent's Brief at 45 n. 30). SARMC also notes a portion ofMRIA's brief 
where MRIA discussed SARMC' s promotion of certain technology for IMI which placed IMI in 
9 Because MRIA showed damage to the competitive market, SARMC's argument that its 
behavior merely constitutes a "business tort" and not anticompetitive conduct is inapposite. 
(Cross-Respondent's Response, at 46-47). See Conwood Co., L.P. v. US. Tobacco Co. 290 F.3d 
768, 783 -784 ( 6th Cir. 2002) (noting that business torts do not constitute anticompetitive 
conduct absent a "significant and more than a temporary effect on competition"). 
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a better competitive position. (Respondent's Brief at 9). SARMC takes these comments out of 
context. 
In its opening brief, SARMC argued that there had been no showing that its breaches of 
fiduciary duty, breaches of the non-compete agreement, tortious interference and bad faith 
caused "lost scan" damage to MRIA. (Appellant's Brief at 31-36). Citing to antitrust cases, 
SARMC suggested that MRIA was required to prove "what proportion of the scans that migrated 
from MRIA to IM! did so as a result of Saint Alphonsus's alleged misconduct, as opposed to 
other causes, such as !Mi's entry into the competitive marketplace." Id. at 31. MRIA countered 
this argument by stating that (I) !MI and SARMC were one in the same, (2) SARMC was a 
partner in !MI, (3) !MI entered the market with SARMC's assistance, and that (4) SARMC and 
GSR conspired to shift scans from MRIA to !MI. (Respondent Brief at 41-47 .) 
In the specific portions of its Respondent's Brief noted above, MRIA further argued that 
SARMC was inappropriately conflating antitrust arguments with breach of fiduciary duty/breach 
of contract arguments. MRIA explained that in the latter cases, to prove causation a plaintiff 
need only show the defendant competed in violation of some agreement or duty and acquired 
customers that were historically customers of the plaintiff. Vancil v. Anderson, 71 Idaho 95, !05, 
227 P.2d 74, 79 (1951) (holding that to prove causation in a non-compete case, the evidence 
must show that "plaintiff business suffered a loss of profits by reason of its patrons and 
customers trading with defendant"). MRIA contrasted this with antitrust cases, where the 
plaintiff must show that the damages came from an antitrust injury rather than competition by 
itself. Pope, 103 Idaho at 233-34, 646 P.2d at 1004-05 (1982); Cargill, Inc. v. Monfort of 
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Colorado, Inc., 479 U.S, l 04, l I 6, I 07 S.Ct. 484,492 (1986). MRIA's comments in its brief 
that "competition was the actionable conduct" (Respondent's Brief at 45, n. 30) and that 
SARMC had given !MI a competitive edge (Id. at 9), merely clarified, contrary to SARMC's 
assertions otherwise, that competition is the appropriate source of the damages in breach of 
fiduciary duty/breach of contract cases. 
Those arguments are not incompatible with MRIA's antitrust claims. SARMC did not 
enhance competition by assisting !Mi's entry into the market. Instead, SARMC destroyed 
competition. As demonstrated in Part I.A.4.b.i through Part I.A.4.b.ix above, SARMC used its 
considerable market power (i.e., its relationship with referring physicians) to destroy MRIA's 
business in favor of IM!. SARMC acted "without legitimate business purpose" to eliminate 
competition and it did so through predatory behavior. Gen. Indus. Corp., 810 F.2d at 804; Aspen 
Skiing Co., 472 U.S. at 605, 105 S.Ct. at 2859. Thus, whereas it was SARMC's competition 
with MRIA that caused MRIA damages for purposes ofMRIA's non-antitrust claims, it was the 
way that competition was conducted that gives rise to MRIA's antitrust claim and injury. The 
claims are not incompatible. 
5. Even ifMRIA Was Required to Present Evidence of Market Power to 
Sustain its Antitrust Claims, MRIA Satisfied that Requirement. 
Although not required for MRIA to proceed on its Idaho law based antitrust claims, 
MRIA presented ample evidence that SARMC/IMI had the ability to achieve monopoly power in 
the provision of MRI services. To succeed on an attempted monopolization claim, a plaintiff 
must show that there is a dangerous probability that the defendant will achieve "monopoly 
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power." Spectrum Sports, Inc. v. McQuillan, 506 U.S. 447,456,113 S.Ct. 884,891 (1993); 
Cascade Health Solutions v. Peacellealth, 515 F.3d 883,893 (9th Cir. 2008); Pope v. 
Jntermountain Gas Co., 103 Idaho 217, 229, 646 P.2d 988, 1000 (1982). "Monopoly power is 
the 'power to control prices or exclude competition' in the relevant market." Image Technical 
Services, Inc. v. Eastman Kodak Co., 125 F.3d 1195, 1202 (9th Cir. 1997)(citing United States 
v. E.I. DuPont DeNemours & Co., 351 U.S. 377,391, 76 S.Ct. 994, 1005 (1956)). 
To determine whether a defendant is dangerously close to obtaining monopoly power, "it 
is necessary for the court to measure and evaluate the degree of market power which the 
defendant possesses." Pope, 103 Idaho at 229,646 P.2d at 1000. In determining whether there 
is a dangerous probability of monopolization, courts "consider the relevant market and the 
defendant's ability to lessen or destroy competition in that market." Spectrum Sports, 506 U.S. 
at 456, 113 S.Ct. at 891. "[D)emonstrating the dangerous probability of monopolization in an 
attempt case ... requires inquiry into the relevant product and geographic market and the 
defendant's economic power in that market." Id. Monopoly power is often referred to as 
"market power," and can be proven by either direct or circumstantial evidence. Image Technical 
Services, 125 F.3d at 1202. 
MRIA presented evidence of market power through the affidavit, report, and deposition 
testimony of its economics expert, Mr. Whitelaw. Specifically, MRIA showed that as IM!' s 
market share was increasing, its prices rose above the market for the same services. (R., Ex. 144 
at ,r 2-4; R., Ex. 110 at Ex. A, p. 2; R., Ex. 104 at Ex. D, p. 50: 1-23). In his affidavit Mr. 
Whitelaw presented evidence that: 
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• "IMI increased its market share while receiving higher payments for patient 
seeking similar services of comparable quality." (R., Ex. 144 at~ 2). 
• "My analysis revealed that IMI's market share steadily increased over time and 
will likely continue to increase. (Id, at 1 3 ). 
• "I concluded that during 2001-2006, IMI received higher payments for providing 
services of comparable quaHty to similar patients relative to those received by 
other sellers. Higher payments coupled with increasing market share indicated 
that IMI possesses and has exercised market power in the relevant market." (Id. 
at 14). 
In his report, Mr. Whitelaw made the following gennane statements: 
• "Based on our analysis ... the market share of the IMI-SADC imaging 
partnership increased from approximately 21 ~23 percent in 2001 to approximately 
44~53 percent in 2006. Based on these results I conclude that the partnership has 
a dangerous probability of achieving a monopoly share of the relevant market, if 
they have not already done so. (R., Ex. 1 IO at Exhibit A, p. 2; see also id at 7-12 
for supporting data). 
• "I conclude that the IMI-SADC imaging partnership has banned competition in 
the re}evant market by receiving h1gher-than-market rates from taking MRI scans 
relative to what these rates would have been in the absence of such 
anticompetitive behavior. (Id. at 2; see also id. at 13-14 for supporting data) 
Mr. Whitelaw also made these points in his deposition. (R., Ex. 104 at Ex. D, p. 50:1-23.)1° 
10 SARMC attacks the strength and reliability of Mr. Whitelaw's analysis and conclusions. 
(Cross-Respondent's Brief, p. 52~53). This is an inappropriate argument in the review of a 
summary judgment decision, where the facts must be liberally construed and all inferences will 
be drawn in favor of MRIA, the non-moving party, Fenn, 142 Idaho at 778, 133 P.3d at 1243. 
Furthermore, SARMC's contentions are incorrect. SARMC argues that Mr. Whitelaw's 
report does not take into account the actual prices charged to consumers. On the contrary, Mr. 
Whitelaw's report indicates that he "calculat[ed] the statistical relationship between the amounts 
paid by [an insurance provider] for MRI scans provided by IMI and all other providers." (R., Ex. 
104 at Ex. G, p. 13). SARMC also argues that Mr. Whitelaw's report inappropriately excluded 
data from another market participant, St. Luke's. On the contrary, Mr. Whitelaw's report 
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a. Exclusive Output Is Not the Exclusive Form of Direct Evidence to 
Prove Market Power. 
The combination of the trends of increasing market share and higher prices is direct 
evidence that SARMC could and did control prices in the market. SARMC nevertheless argues 
that MRIA was required to present evidence of "restricted output" to show direct evidence of 
market power. Restricted output refers to circumstances where, by restricting its own output, a 
predator in the market restricts market-wide output and thereby increases market prices. Rebel 
Oil Co., Inc. v. Atlantic Richfield Co., 51 F.3d 1421, 1434 (9th Cir. 1995). SARMC relies on 
Ninth Circuit cases which state that direct proof of market power "may be shown by evidence of 
restricted output and supracompetitive prices." Forsyth v. Humana, Inc., 114 F.3d 1467, 
14 75 (9th Cir. I 997) ( emphasis added). 11 See Rebel Oil Co., Inc. v. Atlantic Rich.field Co., 51 
F .3d 1421, l 434 (9th Cir. 1995). 
"The defining characteristic of direct evidence is that it demonstrates actual injury to 
competition." In re Abbott Laboratories Norvir Anti-Trust Litigation, 562 F.Supp.2d 1080, 
I 086 (N.D.Cal. 2008). As such, it is absurd to read the Ninth Circuit cases cited above as 
dictating the only type of acceptable direct evidence of the injurious exercise of market power to 
indicates that he made his calculation both with St. Luke's data inserted and without, and that 
both sets of data indicate that IMI received higher payments. Id. (Indeed, removing the St. 
Luke's data is to IMI's benefit, because it suggests that overpayment to IMI was not as 
egregious). 
11 In Forsyth, the Ninth Circuit stated that a mere increase in price is not sufficient to show that a 
defendant has market power. Forsyth, 114 F.3d at 1476. Unlike Forsyth, however, MRIA has 
shown more than an increase in price. It has shown both IMI's increasing market share and a 
contemporaneous increase in price as that market share has grown. 
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be restricted output. Id. As the United States Supreme Court has said, "'proof of actual 
detrimental effects, such as a reduction of output,' can obviate the need for an inquiry into 
market power, which is but a 'surrogate for detrimental effects.'" FTC. v. Indiana Federation 
of Dentists, 476 U.S. 447, 460-461, 106 S.Ct. 2009, 2019 (1986) (citing 7 P. Areeda, Antitrust 
Law, 1511, p. 429 (1986) (emphasis added).) 
This illustrative example by the Supreme Court does not limit the kinds of direct proof 
that might exist. While high prices in conjunction with reduced output are one way of showing 
market power, it is not the exclusive means of proving actual detrimental effects in the market. 
Contrary to SARMC's argument, an increase in prices above the competitive level, as presented 
by MRIA, may establish that monopoly power exists. See U.S. v. Microsoft Corp., 253 F.3d 34, 
51 (D.C. Cir. 2001) (when evidence shows that firm has in fact profitably raised prices above 
competitive level, monopoly power exists); American Council of Certified Podiatric Physicians 
and Surgeons v. American Bd. of Podiatric Surgery, Inc., 185 F.3d 606, 623 (6th Cir. 1999) 
("The price difference, coupled with the larger market share. supports plaintiff's claim of 
monopoly power by [the defendant)." (Emphasis added)); Natsource LLC v. GFI Group, Inc., 
332 F. Supp. 2d 626, 635 (S.D.N. Y. 2004) ("Market share is just a way of estimating market 
power, which is the ultimate consideration. When there are better ways to estimate market 
power, the court should use them. These ways include a contemporaneous rise in price with 
increased market share." (Internal citations omitted and emphasis added).) 
As noted above, "[ m ]onopoly power is the 'power to control prices or exclude 
competition' in the relevant market." Image Technical Services, Inc. v. Eastman Kodak Co., 125 
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F.3d 1195, 1202 (9th Cir. 1997). The proof presented by MRIA of a contemporaneous rise in 
price with increased market share is direct and perfectly appropriate evidence that SARMC and 
IMI actually exercised monopoly power. 
b. Circumstantial Evidence Is Also Appropriate to Establish Monopoly 
Power. 
The Court could alternatively hold that Mr. Whitelaw's affidavit, report, and deposition 
testimony showing increasing market share and increasing price provides circumstantial 
evidence of monopoly power. To demonstrate market power by circumstantial evidence, a 
plaintiff must: "( l) define the relevant market, 12 (2) show that the defendant owns a dominant 
share of that market, and (3) show that there are significant barriers to entry and show that 
existing competitors lack the capacity to increase their output in the short run." Image Technical 
Services, Inc. v. Eastman Kodak Co. 125 F.3d 1195, 1202 (9th Cir. 1997) (citing Rebel Oil, 51 
F.3d at 1434. 
"A rising [market] share may show more probability of success of achieving [ a 
monopoly] than a falling share." M & M Medical Supplies and Service, Inc. v. Pleasant Valley 
Hosp., Inc., 981 F.2d 160,168 (4th Cir. 1992). As the Idaho Supreme Court has said, there is 
"no set degree or percentage of market power which must be possessed in order for a defendant 
to be dangerously close to achieving a monopoly." Pope, 103 Idaho at 229,646 P.2d at 1000. 
12 A description of the relevant market is contained in Mr. Whitelaw's report. (R., Ex. 110 at Ex. 
A at 3-6.) The parties previously used this is the definition of the market (see R. Vol. IX at 
1619), and there is no disagreement on this point on appeal. 
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See Rebel Oil, 51 F.3d at 1438, n. 10 (declining to adopt bright-line market percentage rules). 
Instead, "the extent of market power must be evaluated in conjunction with prevailing market 
conditions, as well as the business policies and performance of the defendant." Pope, 103 Idaho 
at 229; see also Theme Proinotions, Inc. v. News America Marketing FSI, 546 F.3d 991, 
1002 (9th Cir. 2008) ("We have determined that a 45-70% market share may be enough to 
establish a substantial share of the relevant market where it is accompanied by other factors."). 
MRIA showed that IM! had a 40 to 50 percent market share that was steadily increasing, well 
within the range of the "substantial share of the relevant market" required by Idaho courts. 
Notwithstanding this, SARMC argues that this percentage is insufficient to show market 
power in the absence of evidence showing "barriers to entry." Generally, the ability of new 
competitors to enter a market is relevant because, if entry is easy, even a firm holding a 
commanding percentage of the market cannot charge a price above the competitive price, for 
once it does, competitors will enter the market and undercut the firm's price. See United States 
v. Syujy Enters., 903 F.2d 659, 667 (9th Cir. 1990). Barriers to entry are significant because they 
"constrain[] the normal operation of the market to the extent that the problem is unlikely to be 
self-correcting." Rebel Oil, 51 F.3d at 1439. 
In this case, rather than analysis of hypothetical barriers to entry, the parties and the court 
were in a better position to evaluate any barriers to entry in light of the ex post description of the 
relevant market, including IMI's increasil!g market share and its persistently higher prices for six 
years. Despite any net entry that may have occurred (and, indeed, according to SARMC, which 
did occur), this failed to offer enough market discipline to eliminate IMI's combination of 
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increasing share and higher prices. Cf Rebel Oil, 51 F.3d at 1440-41 ("Barriers may still be 
'significant' if the market is unable to correct itself despite the entry of small rivals."). An 
estimation of what may prospectively happen through a "barriers to entry" analysis is no 
substitute for examining and analyzing what actually did happen. Here, where MRIA showed 
that IMI owned an increasing 40 to 50 percent market share and was able to charge higher prices 
than the rest of the market for comparable services regardless of entries into the market, MRIA 
has shown market power sufficient to survive summary judgment. 
II. CONCLUSION 
For the foregoing reasons the trial court's (1) refusal to submit the issue of punitive 
damages to the jury should be reversed in the event the Court grants SARMC a new trial because 
MRIA proved, through clear and convincing evidence, conduct sufficient to justify an award of 
punitive damages and (2) the dismissal ofMRIA's antitrust claims should be reversed in the 
event the Court grants SARMC a new trial because MRIA sufficiently asserted an antitrust claim 
under both Idaho and federal law. 
Dated: January 29, 2009 Respectfully Submitted, 
~--~ 
Thomas A. Banducci 
Wade L. Woodard 
BANDUCCI WOODARD SCHWARTZMAN PLLC 
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Boise, ID 83 702 
Attorneys for Respondent 
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Defendants/Counterclaimants/Third Party 
Plaintiff MRI Associates, LLP 
DEC 2 0 2006 
IN THE DISTRICT COURT FOR THE FOURTH JUDICIAL DISTRICT 
OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF ADA 
SAINT ALPHONSUS DIVERSIFIED CARE, INC., an Idaho nonprofit corporation, 
Plaintiff, 
v. 
MRI ASSOCIATES, LLP, an Idaho limited liability partnership, 
Defendant. 
Case No. CV OC 0408219D 
MRI ASSOCIATES, LLP, an Idaho limited liability partnership, 
CounterClaimant, 
V. 
SAINT ALPHONSUS DIVERSIFIED CARE, INC., an Idaho nonprofit corporation; 
1 
SAINT ALPHONSUS REGIONAL MEDICAL CENTER, 
CounterDefendants. 
MRI ASSOCIATES, LLP, an Idaho limited liability partnership, 
Third-Party Plaintiff, 
VS. 
INTERMOUNTAIN MEDICAL I.t\1AGING, LLC, an Idaho limited liability company; 
GEM STATE RADIOLOGY, LLP, an Idaho limited liability partnership; and IMAGING 
CENTER RADIOLOGISTS, LLP, an Idaho limited liability partnership, 
Third-Party Defendants. 
AFFIDAVIT OF PROFESSOR DOUGLAS M. BRANSON 
Douglas M. Branson, being first duty sworn, deposes and says: 
I. I am the W. Edward Sell Chair.in Business Law at the University of Pittsburgh 
School of Law and have occupied that position since September 1, 1996. 
2. Prior to September 1, 1996, I was a Professor of Law at Seattle University, 
Seattle, Washington. I have also been a visiting professor of law at, inter alia, University 
of Oregon, Cornell University, and Washington University (St. Louis, Mo.). I was the 
Charles Tweedy Distinguished Visiting Professor in Business Law at the University of 
Alabama School of Law in 1993 and again in 2003. 
3. I reside at 810 St. James Street, Pittsburgh, Pennsylvania 15213, and at 193 Raft 
Island, Gig Harbor, Washington 98335. 
4. I am a member of the bars of Ohio, Illinois, Washington, and Pennsylvania. I 
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am also admitted to practice before the United States Supreme Court and various federal 
circuit courts of appeal and district courts. 
5. I teach, lecture continuing legal education groups, and consult extensively in the 
area of business organizations, including unincorporated entities, business planning, 
corporate finance, mergers and acquisitions, corporate governance, comparative corporate 
governance, and securities regulation. From time to time, I have also taught the courses in 
agency and partnership, bankruptcy and accounting for lawyers. 
6. I received my Bachelor of Arts cum laude (Economics) from the University of 
Notre Dame in 1965, my Juris Doctor cum laude from Northwestern University in 1970, 
and my Master of Laws from the University of Virginia in 1974, where I ranked first in my 
class. 
7. I am the author of several books and treatises, including DOUGLAS M. 
BRANSON, CORPORATE GOVERNANCE (Lexis Law Publishing 1993)(with annual 
supplements); DOUGLAS M. BRANSON, PROBLEMS IN CORPORATE 
GOVERNANCE (Cathedral Press 1997); DOUGLAS M. BRANSON, 
UNDERSTANDING CORPORATE LAW (Matthew Bender Co. 1999)(2d ed. 2004)(with 
A. Pinto); QUESTIONS AND ANSWERS ON BUSINESS ORGANIZATIONS 
(LexisNexis 2004); DOUGLAS M. BRANSON, INSIDE THE BOARDROOM (2003); 
and DOUGLAS M. BRANSON, NO SEAT AT THE TABLE (NYU Press 2007). 
8. I am the author of approximately sixty law review articles in the areas of 
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business organizations, governance, mergers and acquisitions, and securities regulation, 
including articles in Cornell Law Review, Tulane Law Review (2), Vanderbilt Law 
Review (2), Emocy Law Journal, Northwestern University Law Review (2), Minnesota 
Law Review. Journal of Corporate Law, Nebraska Law Review, Fordham Law Review, 
Corporate Practice Commentator (3), Marvland Law Review, University of Pittsburgh 
Law Review, Cornell International Law Journal, Case Western Reserve Law Review, 
Pepperdine Law Review, University of Cincinnati Law Review, South Carolina Law 
Review, Southern Methodist Law Review, Wake Forest Law Review, Arizona State Law 
Journal, Washington University Law Quarterly, Oregon Law Review, Securities 
Regulation Law Review, and other legal periodicals and journals. 
9. In the last 25 years I have lectured continuing legal education and business 
groups on issues, practices, and customs in business organizations (partnerships, limited 
liability partnerships, limited partnerships, limited liability companies, corporations, 
professional service corporations) and governance and in mergers and acquisitions in 
Hawaii, Alaska, California, Washington, Oregon, Idaho, Ohio, Pennsylvania, Florida, 
Louisiana, and New York. Overseas, I have lectured groups on governance issues and 
practices in, inter alia, Spain, France, Belgium, Germany, South Africa, the United 
Kingdom, Australia, Indonesia, Malaysia, and Hong Kong. 
10. I hold a permanent appointment as a Senior Fellow at the School of Law, 
University of Melbourne, Australia, where for the last thirteen years I have co-taught the 
4 
graduate law offerings Corporate Governance and the Duties of Directors. 
11. From 1976 to 1996, I served on, and actively participated in the affairs of, the 
Washington State Bar Association (WSBA) Corporate Law Revision Committee. I also 
served on the WSBA Securities Law Committee (1986-1994), the Vi'SBA Limited 
Partnership Act Revision Committee (1983-85), the Not-For-Profit Corporation Law 
Revision Committee (1979-85), and the WSBA Committee to Evaluate the Revised 
Uniform Partnership Act (1995-96). 
12. I am an elected member of the American Law Institute. I was elected to 
membership in 1981. From 1981 to 1994, I was an active participant in the American Law 
Institute Corporate Governance Project and a member of the advisory committee which, 
periodically, consulted with the Project's reporters. 
13. From 2000-2002, I was a United States State Department consultant to the 
Republic of Indonesia on business organizations law, governance, capital markets, and 
asset securitization refonn 1n 2000, I was a Fulbright Scholar at the University of Gent, 
Belgium, lecturing on corporate law and corporate governance. 1n 2003, I was a State 
Department consultant to Ukraine, assisting on projects regarding partnerships and law 
firm organization. In 2006, I was the Paul Hastings Distinguished Visiting Professor at the 
University of Hong Kong, where I lectured, inter alia, at the Hong Kong Futures and 
Exchange Commission and the Asian Development Bank on corporate governance. In 
2006, I was a consultant to US Steel Corp., lecturing attorneys and executives from Serbia, 
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Slovakia, and the United States on U.S. business law. 
14. I am being compensated at $400 per hour. 
15. In connection with this case, I have reviewed numerous documents, including 
court papers (Complaint, Answer and Counterclaim, Scheduling Order, Court's 
Memorandum Opinion Finding, inter alia, Wrongful Dissociation); deposition excerpts 
(Christopher Anton, Sandra Bruce, Jeffery Cliff, Jack Floyd, Kenneth Fry, Leslie Kelly 
Hall, Cindy Schamp, Jeffrey Seaboum, and Patricia Vandenberg); Agreements and Drafts 
of Agreements, including term sheets (MRIA Partnership Agreement and First 
Amendment thereto; SARG/GSR Exclusive Services Agreement with SARMC; 
Intermountain Medical Imaging LLC Operating Agreement, including several preliminary 
drafts; various Term Sheets outlining the terms upon which SARMC would invest in IMI; 
Medical Director Employment Agreement; Information Resources Agreement); minutes of 
meetings (IMI, MRIA, :MRICI, MRIM, SARG/GSR; ICR); consultants reports (Shattuck 
Hammond Partners Preliminary Report by M. Finnerty and "Presentation of Strategic 
Options" by Shattuck Hammond Partners); letters from attorney and other independent 
contractors (Leo Miller, Esq., to Sister Patricia Vandenberg dated March 5, 1985; Carl W. 
Harder, Esq. to Ms. Sandra Bruce dated January 6, 2000; Patrick Miller, Esq., to Joseph 
Uberuaga II, Esq., July 13, 2000; memorandum from Patti Hameck to Leslie Kelly Hall 
dated January 31, 2002, re IMI use of SAR.MC DR Server; Memorandum from J. Tim 
Hall, MD, to :MRI Center Scheduling Department re "Mission Creep," and miscellaneous 
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(SARMC 1122 application for Certificate ofNeed; US Bank documents re proposed IMI 
loan; Power Point Slide Deck Entitled Interrnountain Medical Imaging, A Joint Venture 
Partnership Between St. Alphonsus Radiology Group and SARMC, dated Nov. 11, 1999; 
PricewaterhouseCoopers outlines of SARMC Scenarios Nos. 1-5; Restructuring of MRI 
Associates, Discussion Draft dated Nov. 29, 1999; Health Technology Center, Report on 
the Future of Medical Imaging II: P ACS, August, 2003); SARMC Withdrawal Letter 
dated February 24, 2004, and Demand for Payment Letter, dated March 30, 2004; 
SARG/GSR correspondence by Jeffrey Seabourn re termination of GSR services at MRI CI 
and ofMRICI access to DR/Web Ambassador network, and the subsequent reinstatement 
thereof; email from Jeffrey Cliff to Carl Harder, Esq., listing investments SARMC had 
made in IlvII prior to August 10, 1999. 
16. In addition, on Thursday, December 7, 2006, I spent approximately 9 hours at 
the law offices of Greener, Banducci Shoemaker, P.A., Boise, Idaho, reviewing 
documents, correspondence and deposition excerpts relevant to this case. 
17. Based upon my review of the foregoing, in my opinion, SARMC knowingly 
engaged in conduct that was an extreme deviation from the standards of conduct partners 
owe in a partnership in that it repeatedly served the best interests of competitors (IMI, 
ICR, and SARG/GSR) rather than the best interests of the MRIA Partnership, of which it 
was a partner. As an experienced business law practitioner, I would have advised SARMC 
that, in every instance, over and above what the partnership agreement expressly provided, 
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SARMC's duty was to serve the best interests of the N1RIA partnership and its fellow 
participants in the partnership. 
18. In my opinion, SARMC engaged in a further extreme departure from the 
applicable partnership standard of conduct by its wrongful dissociation, without any 
colorable grounds therefor, and despite warnings from authoritative sources 
(PricewaterhouseCoopers, Shattuck Hammond Partners) that such a dissociation would be 
wrongful. 
19. In my op-inion, SARMC further departed from the applicable partnership 
standard of conduct by efforts to dissociate from the partnership in bad faith, apparently 
attempting to inflict harm on the N1RIA partnership and the other partners therein by, inter 
alia, wrongfully demanding immediate payment for its partnership interest; preparing a 
portable MRI unit pad in the SARMC parking lot; threatening to restrict MRJCI's access 
to the SARMC DR server and P ACS. systems, which required MRJCI to build its own 
PACS/RlS system; condoning or facilitating the curtailment of services and availability of 
SARG/GSR radiologists at MRICI; simultaneously condoning or facilitating the expansion 
of services and availability of SARG/GSR physicians at the competing !MI facilities; and 
in general pursuing what it termed a "scorched earth" approach to its attempted 
dissociation. 
20. In addition to having departed from the standards of conduct which govern 
partners in a partnership, SARMC violated the express provisions of the N1RIA 
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Partnership Agreement by its attempted withdrawal from the MRIA Partnership without 
any colorable grounds, or any grounds at all, therefor. 
21. SARMC violated the express provisions of the MRIA Partnership Agreement 
by competing, alone and through its affiliate, IMI, with the MRIA Partnership, in violation 
of the express covenant not to compete contained in the MRIA Partnership Agreement. 
22. SARMC usurped a partnership opportunity, and aided and abetted the 
usurpation of a partnership opportunity by another, in providing information technology, 
telecommunications, records storage and retrieval, human resources, experienced 
personnel and other services, without distinction between MRI and non-MRI Jines of 
business, to the IM1 9th and Myrtle diagnostic imaging facility in Boise, Idaho. 
23. Similarly, SARMC usurped a second partnership opportunity, and aided and 
abetted the usurpation of a partnership opportunity by another, in providing information 
technology, telecommunications, records storage and retrieval, human resources, 
experienced personnel and other services, without distinction between MRI and non-MRI 
lines of business to the diagnostic imaging facility in Meridian, Idaho. 
24. In support of the opinions expressed, supra paragraphs 17-23, I would note that 
SARMC committed the following acts prior to the commencement of business by IM1 at 
the downtown Boise imaging center: 
• In order to obtain U.S. Bank financing for the IMI facility, represented, or 
allowed the representation to be made, that SARMC would "partner" with 
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SARG/GSR physicians in forming and operating a new facility. 
• Provided l\1RIA and MRICI data, in SARMC's possession and control, as to 
case volume, technical component charges, staffmg levels, and operations 
data for use iu formulation of the IMI business plan. 
• Linked IMI and its imaging facility to the SARMC intranet and attending 
physician network. 
• Converted to another vendor and commenced utilization of DR Systems so 
as to become compatible with the IMI computer network. 
• Supported the transfer of key MRlCl personnel to a putative competitor, 
IMI, including Karen Noyes, assistant director of Radiology, SARMC, to 
IMI Executive Director of Operations. 
• Reviewed and approved pro forma projections IMI prepared. 
25. In support of the opinions expressed, supra paragraphs 17-23, I would note 
that SARMC committed the following acts from the time at which IMI opened its first 
imaging facility (August 1999) and the time at which SARMC formally entered into the 
IMI LLC Operating Agreement: 
• Failed to investigate complaints of reduced care/hours of service by 
SARG/GSR physicians to MRI Center operations, as well as to patients 
referred to the center. 
• Insisted that SARG/GSR physicians continue to read MRI CI images even 
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after SARG/GSR physicians had opened a competing venture (IMI) and a 
caution issued by a local health care attorney, Carl Harder, that adherence to 
an exclusive services arrangement by competitors ofMRIA would result in 
breaches of fiduciary duty. 
• Insistence that SARG/GSR physicians provide exclusive services despite 
knowledge that physicians had intentionally curtailed hours and levels of 
service. 
• Continued to provide infrastructure support (information technology, 
including access to $350,000 DR server, telecommunications, transcription, 
disaster recovery, down time and other services) without distinction between 
MRI and non MRI lines of IMl business. 
• Provided confidential MRIA partners' and partners' relationship information 
toIMI. 
• Opposed further growth of MRI Mobile (MRIM) despite robust growth of 
that business. 
26. In support of the opinions expressed, supra paragraphs 17-23, I would note that 
SARMC committed the following acts between the time at which it executed the IMl LLC 
Operating Agreement (July 1, 2001) and the time at which it attempted to withdraw from 
the MR.IA Partnership (LLP as of April 2003) by letter dated February 24, 2004, to be 
effective April 1, 2004: 
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• 
Executing an agreement to sell one half ofMRIA when SARMC did not 
own one half, without disclosing to its MRIA partners details of the 
exchange offer to which it had agreed. 
Condoning or assisting in disparagement, curtailment of physician services, 
and other activities which would drive down the value of partnership 
interests in the MRIA Partnership but which SARMC might acquire in the 
future. 
• Contributing $546,347 in equity capital (which would be commingled with 
• 
• 
• 
other IMI funds) and assuming responsibility for $1.6 million in bank loans 
without distinction between MRl and non MRl lines ofIMI's business. 
Entering into a 50-50 operating agreement with another 50 percent LLC 
member, which made the LLC an "affiliate," thereby contractually 
prohibited from the competition in which it was and had for some time been 
engaged. 
Utilizing SARMC employees who had duties and responsibilities to MRIA 
as SARMC's representatives on the IMI Board of Managers, which managed 
all ofIMI's activities, without distinction between MRl and non MRl lines 
of business. 
Forming an IT/P ACS committee exclusively of SARMC and IMI 
representatives, thereby freezing MRIA out of discussions regarding 
12 
important P ACS developments. 
• Permitting or facilitating dual allegiances, and then the transfer of 
allegiances and loyalties, of key independent contractors from N1RIA to IMI. 
• Making extortionate demands at the time of withdrawal, insisting on 
immediate payment despite knowledge that withdrawal was wrongful and 
that observance of a one year covenant not to compete was independent of 
payment vel non. 
27. In addition, a partner engages in a radical and extreme departure from the 
standards applicable to dealings between or among partners when it makes affirmative 
misrepresentations, tells half truths, or dissembles, to one or more of its fellow partners, 
either in response to inquiries from its partners, or on its own volition. In my opinion, in 
the case at bar, SARMC told a number of untruths and made the following 
misrepresentations, which constituted independent violations of the standards applicable to 
partners in a partnership: 
A). SARMC would not support MRI operations at IMI LLC when in fact it did, 
over a period of several years. 
B). SARMC had no plans for participation in any Meridian, Idaho diagnostic 
imaging facility, when it in fact did have plans. 
C). SARMC not only failed to disclose but actively concealed its commitment to 
pursue a Meridian, Idaho facility in connection with IMI. 
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D). Dissembled regarding the undisclosed service by key SARMC employees on 
the boards of managers, or of partners, respectively, of the competing entitles, IM! and 
MRlA, .in the latter of which SARMC was a partner. 
E). Failed to disclose to its partners the provision of confidential MRlA financial 
information to potential third party investors or putative lenders to SARMC. 
F). Misrepresented the affiliate status ofIMI once SARMC had become a signatory 
to the IMI Operating Agreement, with 3 of 6 SARMC managers on the IMI Board of 
Managers. 
G ). Did not accurately disclose the extent of its $2. I million investment and the use 
(commingling) of the investment in support ofIMI's MRI as well as its non MRI lines of 
business. 
H). Falsely asserted, via a court complaint and otherwise, that SARMC was free of 
restraints on withdrawal from the MRlA Partnership, when it knew otherwise and had 
been so informed by authoritative professionals and consultants. 
I). Inferred, or told, untruths regarding the coverage of the covenant not to compete 
contained in the partnership agreement, asserting that the covenant would only be effective 
ifMRIA bought out SARMC within 120 days, when the agreement contained no such 
provisions and provided otherwise (that is, the covenant applied in any event). 
28. Partners owe to all participants in a partnership not only a duty of loyalty but a 
duty of the "utmost good faith and loyalty" and a "punctilio of an honor the most 
14 
sensitive." In my opinion, the acts of SARMC and those who aided and abetted their 
violations of fiduciary duty, including failures to act, represented an extreme deviation 
from the standards of conduct partners owe in a partnership and appear to have been 
conducted in a wilful and deliberate manner. 
,...ot;--
GIVEN this / 6 day of December, 2 0 
County of Allegheny ) 
) 
Commonwealth of Pennsylvania ) 
Sworn to and subscribed before me on this 1511-lday of December, 2006. 
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COMMONWEALTH OF PENNSYLVANIA 
Notarial Seal 
Caroline M. Deasy, Notary Public 
City Of Pittsburgh, Allegheny County 
MyCommiss,on Exp,res Feb. 12. 20to 
Member, Pennsylvania Association of Notaries' 
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.EXHIBITB 
EXHIBITB 
From: 
To: 
Date: 
Subject: 
<allen.hahn@us.pwcglobal.com> 
SARMC.PO-SARMC(SARABRAT) 
Wed, Jan 5, 2000 2:40 PM 
Engagement Documents 
Attached are the documents requested by Cindy and Ken. The report on the IMI 
joint venture is draft; please have Cindy/Helen review and call w/any comments. 
We will send a final copy after suggested edits are incorporated. Also Is 
"Scenario 5" which Ken requested based on our reading of the relevant 
partnership documents. A FEDEX will arrive tomorrow with draft copies of beth 
documents. Please call if either Ken or Cindy would like to discuss. 
regards 
(See attached file: Report_lMl_9_ 1_99_final.doc)(See attached file: Scenario 
5.doc) 
The information transmitted is intended only for the person or entity to which 
ii is addressed and may contain conficlentlal and/or privileged material. Any 
review, retransmission, dissemination or other use of, or taking of any action 
in reliance upon, this information by persons or entitles other than the 
intended recipient is prohibited. If you received this In error, please 
contact the sender and delete the material from any computer. 
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January 5, 2000 
CONFIDENTIAL 
Ms. Cindy Schamp 
Chief Operating Officer 
DRAFT -FOR DISCUSSION 
Saint Alphonsus Regional Medical Center 
1055 North Curtis Road 
Boise, Idaho 83706-1370 
Subject: Valuation of 50 Percent Interest in Intermountain Medical Imaging LLC 
Dear Ms. Schamp: 
At your request, we have estimated the fair market value of Saint Alphonsus Regional Medical 
Center's ("SARMC") 50 percent, interest in Intermountain Medical Imaging LLC ("IMI," or "the 
Center"), a joint venture between SARMC and Saint Alphonsns Radiology Group ("SARG"), as 
of September 1, 1999 (the "valuation date") on a going-concern basis. We understand that the 
purpose of this analysis is to assist SARMC's management in its decision concerning the 
valuation of its ownership interest in connection with the formation of the Center. Our valuation 
analysis may not be. used for any other purpose nor distributed to any third parties without the 
prior written consent of PricewaterhouseCoopers LLP ("PwC" or "PricewaterhouseCoopers"). 
Based on the assumptions and limiting conditions as described in this report, as well as the facts 
and circumstances as presented to us by SAR,.\1C' s management for the valuation date, we 
estimate SARMC' s 50 percent interest in IMI to be approximately book value, or no greater than 
SARMC's cash contribution of approximately: 
$622,000 
This report describes the principles, assumptions, and procedures that were applied in our 
valuation analysis of the aforementioned equity interest. The findings stated in this analysis are 
based on data obtained directly from SARMC's management and from sources of publicly 
available information. In addition, certain information in our report is based on our interviews 
with representatives of SAR.i',,iC. Management has advised us that they consider the data used to 
be accurate, and that no information known to them conflicts with the data or resulting use of 
such data in this analysis. 
This Jetter and report should not be used, quoted or circulated in whole or in part for any other 
purpose other than that stated above. The PricewaterhouseCoopers name may not be used or 
referenced in connection with this Jetter and report in any public or private offerings including, 
but not limited to, those filed with the Securities and Exchange Commission or other government 
agencies. In addition, our findings are subject to the Statement of Assumptions and Limiting 
Conditions shown in Appendix I. 
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In the course of our analysis, we performed the following: 
• Read the proposed Te;rm Sheet for Intermountain Medical Imaging LLC; 
• Read the pending Operating Agreement for the Center and associated exhibits; 
• Read IMI's proforma financial statements, including maximum, minimum and anticipated 
profit scenarios; 
• Read the Capital Contributions and Debt Schedule of Intennountain Medical Imaging 
Center; 
• Read the Market Value Appraisal Report of the real property in which IMI leases space; and 
• Considered the impact of current industry trends and developments on the fair market value 
ofIML 
Because the procedures we performed during this engagement were limited in scope and did not 
constitute an attest service as that defined by the American Institute of Certified Public 
Accountants, we cannot express an opinion on the financial, statistical or other data included in 
our analysis or findings. Our valuation analysis in no way constitutes an opinion of fairness to 
any shareholders or an opinion of solvency. · 
According to the provisions of the Internal Revenue Code of 1986 (the "Code") as amended, all 
valuations of the stock of closely held corporations or the stock of corporations where market 
quotations are not available must be made in accordance ,vith Revenue Ruling 59-60 for estate 
and gift tax purposes. 1 Revenue Ruling 65-192, as superseded by Revenue Ruling 69-609, 1968-
2 C.B. 327, extended the concepts in Revenue 59-60 to income and other tax purposes as well as 
to business interests of any type. Closely held corporations are enterprises whose shares are 
owned by a relatively limited number of stockholders. 
An1ong other factors, this valuation analysis considers Revenue Ruling 59-60, which, while not 
prescribing any formula for concluding on value, provides guidance on how to app.roach the 
valuation of business interests. In accordance with this guidance, the following factors, among 
others, have been considered to the extent applicable in our estimate of value for Ilvll: 
A. The U.S. economic outlook in general and the condition and outlook of the 
industry in which IMI operates, in particular; 
B. The nature of the business and history of the enterprise from its inception; 
C. The book value of IMI and the financial condition of the business including its 
need for additional investment funds to realize its business objectives; 
D. The earnings capacity ofIMI; 
E. The dividend paying capacity of IMI; 
1 Internal Revenue Service Ruling 59-60 1959-1 C.B. 237. 
PrtcewaterbouseCoopers LLP Page2 
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F. Whether or not lMI has goodwill or possesses any other intangible value; 
G. Recent sales of the stock and the size of the block of stock to be valued; 
H. The market price of publicly traded stock of corporations engaged in industries or 
lines of business similar to IMI. 
For estimating the value of closely held corporations, Revenue Ruling 59-60 defines fair market 
value as, " ... the price at which the property would change hands between a willing buyer and a 
willing seller when the former is not under any compulsion to buy and the latter is not under any 
compulsion to sell, both parties having reasonable knowledge of the relevant facts"2• The 
hypothetical buyer and seller are assumed to be able, as well as willing, to trade and to be well 
informed about the property and concerning the market for such property. 
Although SARMC's 50 percent interest in IM! is not a controlling interest, the rights provided do 
afford the hospital some elements typically associated with control. According to the proposed 
Term Sheet, the LLC will have, at least initially, two members, each holding a 50 percent interest 
in the Center with equal representation on the Management Committee. Both entities have 
contributed an equal amount of capital and will share equally in the profits and losses of the 
Center. Neither entity has been granted supermajority voting rights nor any other rights which 
would result in one entity having more strategic control than does the other. Given these facts, 
SARMC does have some ability to influence the Center's strategic decisions. We therefore 
consider SARMC's interest to be a significant non-controlling interest rather than a minority 
interest. 
The selection of the appropriate premise of value is an important step in defining the appraisal 
process. Typically, in controlling interest valuation assignments, the selection of the appropriate 
premise of value is a function of the highest and best use of the collective assets of the subject 
business enterprise. When appraising a minority interest, the correct premise of value should 
reflect business as usual for the subject company. In the unique case of valuing a minority or 
non-controlling interest in a start-up company, the tremendous uncertainty about the enterprise 
magnifies the importance of choosing the appropriate premise of value; the value conclusions 
reached under alternative premises of value, for the same business, may be materially different. 
For purposes of this analysis, we considered the fair market value of a 50 percent interest in !Ml 
under the premises of value as a going-concern. 
There are three basic approaches to the valuation of a minority interest in a closely held 
company: (I) a "top down" approach where the total enterprise value is computed from direct 
comparison with the values of controlling interest transactions of guideline businesses, which is 
then reduced by a minority or non-controlling interest discount reflecting its lack of control in 
the total entity; (2) a direct comparison approach that estimates the enterprise value of the subject 
company using values of minority interests in publicly traded guideline companies, which are 
then adjusted for lack of marketability; and (3) a "bottom up" approach which estimates the 
benefits the owners will realize over the life of the investment, considering the effects of lack of 
marketability if no easily accessible market is available to provide liquidity for the investment. 
SARMC08050 
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In arriving at our estimate of aggregate value of SARMC's 50 percent interest in IMI on a non-
. controlling interest basis, we have relied upon the "bottom up" approach. A "top down" 
approach was considered but rejected due to the early-stage nature of the entity. A direct 
comparison with publicly traded guideline companies was not performed because of the life 
cycle differences that exist between private ownership of an early stage company and ownership 
of an established publicly traded company. 
INDUSTRY CONDITION A,."ID OUTLOOK3 
The health care industry (SIC 80) consists of public, private and non-profit institutions. These 
institutions include hospitals, offices and clinics of medical doctors, nursing homes, managed 
care providers such as health maintenance organizations ("HlvfOs"), preferred provider 
organizations ("PPOs"), independent practice associations, and other specialized health care 
facilities. The industry is labor intensive, employing approximately 10 million people in 1996, 
of whom more than 650,000 were physicians. National healthcare expenditures are expected to 
total $1.3 trillion in 1999, of which $235 billion will be spent for physician services. For 
purposes of this report, only the imaging segment of the industry was considered. 
Many hospitals and other health care providers require access to diagnostic imaging services to 
remain competitive in the health care marketplace. At the same time, regulatory and licensing 
requirements in many states may limit access to imaging systems, while health care providers 
may lack the financial resources or sufficient patient volume to justify the high expense 
associated with the purchase of diagnostic imaging systems. Even if financial resources are 
available, some health care providers prefer to contract the services for many reasons, including, 
among others: to obtain the use of the system without any financial risk; to retain the ability to 
switch system types and avoid technological risk; to avoid future uncertainty with regard to 
reimbursement; to eliminate the need to recruit, train and manage qualified technologists; or to 
provide additional imaging services when patient demand exceeds in-house capability. 
The diagnostic imaging segment of the health care industry is highly competitive, with numerous 
small facilities and a few large, diversified healthcare companies in each geographic market. In 
addition to hospitals that provide on-site imaging services, other competitors include multi-center 
imaging companies, local independent diagnostic centers, and imaging centers owned by local 
physician groups. 
In JMI's defined geographic market, Boise already has two major hospitals providing full service 
imaging procedures: Saint Alphonsus Regional Medical Center and St. Luke's Regional Medical 
Center. In addition, there are two other imaging centers: Open MRI of Boise, owned by a 
publicly traded company, and HealthSouth Treasure Valley Hospital. In the state of Idaho, no 
certificate of need ("CON") regulations exist with respect to imaging centers. Consequently, 
other healthcare providers face few barriers to entry and may increase the competitive 
environment in which the Center currently operates. 
SARMC08051 
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In general, there is a growing trend for healthcare services on an outpatient basis, fueled by 
advances in technology, demands for cost-effective care, and concerns for patient comfort and 
convenience. However, the healthcare industry in the U.S. is subject to regulation at the federal, 
state and local levels. Regulations can affect companies' growth, require licenses and/or 
facilities certification, and control the reimbursement to the health care provider for services 
provided. Over recent years, as technology has improved and the population has aged, the scope 
of imaging procedures provided has widened to include more patients covered by Medicare and 
Medicaid. This has resulted in a small but growing percentage of imaging services revenue 
being reimbursed by government programs. Given the uncertainty surrounding government 
reimbursement and regulation, the ability of health care providers to accurately predict their 
financial performance becomes even more difficult. 
NATURE AND HISTORY OF INTERMOUNTAIN MEDICAL IMAGING 
General 
Intermountain Medical Imaging was formed on September I, 1999 as an Idaho Limited Liability 
Company by two members: St. Alphonsus Regional Medical Center, a local hospital, and Saint 
Alphonsus Radiology Group, a physician's group, for the purpose of owning and operating an 
Independent Imaging Center in Boise, Idaho. The Center provides medical imaging services in 
the following areas: computed tomography ("CT'), ultrasound, mammography, and radiography, 
as well as special procedures. In addition, the Center has a computed radiography and picture 
archiving communication system (P ACS) that is integrated with SARMC' s information systems. 
IMI is located in a free-standing imaging center in downtown Boise, ldaho. The Center leases 
4,950 sq. ft. from Gem State Radiology and operates five days per week on a regular basis and 
six days when necessary, a key factor in the delivery of imaging services. 
Capitalization of II.YU as of September 1, 1999 
The Center is a 50/50 joint venture LLC owned and operated by two members: SARMC and 
SARG, both located in Boise, Idaho. As a new business in the diagnostic imaging field, 
significant capital requirements were necessary to begin operations. The investment in 
equipment for start-up operations totalled $3.5 million, while initial working capital 
requirements to fund projected losses amounted to $550,000. The investment in equipment was 
financed by a long-term loan, the conditions of which required a 20 percent down payment, or 
approximately $700,000. In addition to this debt financing totalling approximately $2.8 million, 
each member contributed an equal amount of capital in cash to fund working capital 
requirements and the equipment loan down payment. Total equity of $1.2 million, combined 
with the debt financing, brings the total invested capital of the Center to approximately $4. 0 
million. 
PricewaterhouseCoopers LLP Page 5 
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FINANCIAL REVIEW 
Only a forward-looking financial review of !MI as of the valuation date is possible using the pro 
forma financial statement scenarios contemplated by management. Due to the high level of 
uncertainty surrounding the assumptions and resulting cash flows of the newly fanned Center, its 
projections are not as meaningful as historical operating results of established businesses. 
Financial projections of newly established businesses are typically highly uncertain due to 
forecasting errors experienced when projecting staffing requirements, overhead costs, and 
volmne of services, among other variable expenses. Higher scan volumes allow the company to 
benefit from the operating leverage due to a high fixed cost expense structure, resulting in 
increased profitability. However, the opposite is true of lower scan volumes. As a consequence, 
small changes in revenue can greatly affect profitability, leading to above average financial risk 
In addition, !Ml has entered a highly competitive environment in which it competes with well-
established imaging centers associated with existing physician referral networks. Thus, given the 
operating and financial risk that !MI faces and the highly competitive market in which it 
operates, the achievement of anticipated financial projections is highly uncertain as of the 
valuation date. 
Discussion of Opening Balance Sheet 
IM!' s opening balance sheet as of September 1, 1999 is shown in Exhibit I. As of the valuation 
date, the Center had total assets of approximately $4.0 million; $3.5 million or 86 percent of 
which was classified as fixed assets. Current assets consisted of cash in the amount of $550,000, 
or 14 percent of total assets. 
Total liabilities as of the valuation date were approximately $2.8 million, which represented the 
equipment loan financing used to capitalize the business. In addition, a line of credit is available 
to meet working capital needs, but had not yet been drawn upon as of the valuation date. The 
long-tenn loan was collateralized by the underlying equipment, while the 'line of credit would be 
collateralized by accounts receivable if drawn upon. The high leverage results in substantial 
financial risk for the Center, as evidenced by its high debt to equity ratio of 2.2: l. Debt to total 
invested capital ratio is 69 percent. 
Net Asset Value 
The Center's net asset value ("book value") as of the valuation date was approximately $1.2 
million. As mentioned above, !MI is capitalized with equal cash contributions from each of the 
members as well as the equipment financing, for a total of approximately $4.0 million. Because 
the Center began operations on the valuation date, there was no impact from operations on 
retained earnings, nor the net asset value of the Center. 
In valuing established companies, book value does not necessarily represent going concern 
value, as it is an accounting term, not an appraisal term. Financial statement assets are accounted 
for at historical cost, less depreciation, while some assets may be completely written off for 
financial reporting purposes. Intangible assets nonnally do not appear on the balance sheet 
unless they were purchased or the actual cost of development is capitalized. Neither contingent 
PricewaterhouseCoopers LLP Page 6 
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assets nor contingent liabilities are generally recorded, and liabilities are usually shown at face 
value. Therefore, a company's contributed equity capital may not bear an identifiable 
relationship to·· going concern value for the business as a whole.4 However, in the case of IMI, 
which has no operating history and highly uncertain future earnings, book value is likely a 
reasonable estimate of fair market value. As of the valuation date, IMI began operations. As 
such, the assets have not been depreciated nor written down, there are no identifiable intangible 
assets or contingent liabilities, and the liabilities' face value approximates fair market value. In a 
start-up situation such as this, the net asset value of a company is equivalent to the. contributed 
equity capital, and is a reasonable estimation of the going concern value for the business as a 
whole. 
Intangible Assets and Goodwill 
An intangible asset is a right or non-physical resource that is presumed to represent an advantage 
to the firm in the marketplace. Such assets include copyrights, patents, leases, franchises, and 
goodwill, as well as other assets. "Intangible assets are the elements, after working capital and 
tangible assets, that make the business work and are often the primary contributors to the earning 
power of the enterprise. The existence of intangible assets, including goodwill, is dependent 011 
the presence, or expectation, of earnings."5 Goodwill, as defined by Revenue Ruling 59-60, is 
"the customer patronage of a business, name of the business, ownership of a trade name or brand 
name, location of the business, and a renewal of successful operations over a prolonged period." 
As the evidence of goodwill results from "the measurement of historical or expected earnings in 
excess of the normal industry return 011 all other tangible and intangible assets,"6 ascribing 
goodwill to a start-up business with no operating history and highly uncertain future earnings is 
not appropriate in this instance. 
Prior Transactions 
Revenue Ruling 59-60 lists any previous transactions of stock or recent sale of the entity being 
valued as a factor to be considered in arriving at an estimate of its fair market value. Based on 
our discussions with management, no transactions in IMI's common stock had occurred as of the 
valuation date. 
VALUATION 
Introduction 
A Market Approach establishes the value of a privately-held corporation through analysis of 
transactions of guideline companies. The information derived from this analysis is used to infer 
an opinion of market value for the subject company. In an Income Approach, value is dependent 
upon the present value of future economic benefits to be derived from ownership. A price per 
4 Shannon Pratt, Valuing a Business (Homewood: Dow-Jones Irvin, 1989) p.29. 
5 Smit~ Gordon V. and Parr, Russell L., Valuation of Intellectual Propertv and Intangible Assets, Second Edition, p. 
83. 
'Danzig, Lawrence H., and Robison, Robert A., The Tax Adviser, January 1980, p. 33. SARMC08054 Office of the CFO 
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share or interest is then estimated by discounting the net cash flows available for distribution to 
their present value at market-based rates of return. The Cost Approach focuses on the present; it 
utilizes estimates of the current cost to replace the entity's fixed assets and certain intangible 
assets. 
A valuation analysis of a start-up company typically differs from traditional approaches applied 
to a more established enterprise. A start-up company has a very limited operating history and, as 
such, historical trends and ratios cannot be used to develop financial forecasts. Vihen financial 
projections are available, the achievement of projected results is often highly uncertain and often 
differs from actual results attained. Management of SARMC provided us with several financial 
projection scenarios due to the uncertainty associated with the operations of the entity. For 
example, there is no assurance that physicians will refer patients to IMI over other imaging 
centers or hospitals in the area, a crucial factor in an imaging center's success. These limitations 
and others make it difficult to apply an income approach to valuation, which depends on the 
availability of reasonable and reliable management projections. 
The application of a market comparable approach to valuation is also difficult. A start-up 
company typically has negative earnings and cash flows, while its revenues may be growing very 
quickly. Applying guideline company multiples from recent transactions would likely not yield 
meaningful results. Moreover, publicly traded guideline companies often are much larger than 
the subject start-up company and have achieved stable and somewhat more predictable growth 
rates. The multiples paid by investors for established publicly traded companies reflect both an 
expectation of lower risk and a different level of future growth, and therefore may not be an 
appropriate benchmark of value for a start-up company. 
Asset Accumulation Approach 
Based on our analysis and understanding that !MI began operations on the valuation date, an 
asset based valuation approach is an appropriate method to estimate the fair market value of 
SARMC's 50 percent interest in IMI. An Asset Accumulation Method essentially restates a 
company's balance sheet to fair market. values. This approach involves the identification and 
valuation of otherwise unrecorded tangible and intangible assets, if any, as well as the 
revaluation of the asset and liability accounts already recorded on the company's GAAP balance 
sheet. The value of the individually appraised assets less the value of the individually appraised 
liabilities represents an estimate of the value of the entity. 
The advantage of applying an Asset Accumulation Method, in !MI' s case, stems from its lack of 
operating history and uncertain future as of the valuation date. IM!'s assets and liabilities, 
therefore, had not yet been adjusted and hence, the balance sheet as of the date of formation of 
the Center is a reasonable estimation of the fair market value of the equity of !MI as of the 
valuation date, or approximately $622,000. 
APPLICATION OF DISCOUNTS sARMC08055 
office of the CFO 
The value of SARMC's interest in !Ml, as described above, was prior to any consideration for 
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discounts for lack of marketability or ownership interest transfer restrictions. As with most 
closely held enterprises, the factors that may give rise to a discount for lack of marketability 
include: a lack of willing buyers for the interest; an uncertain time horizon to complete a 
potential sale; the cost of the sale or liquidation, as well as the risk as to the eventual form of 
transaction proceeds; restriction on transferability of interest; and the intent of the owners with 
regard to the investment. In the case of the Center, there is no public market for its equity as of 
the valuation date, nor is a public market anticipated. Transfer of SARMC's ownership interest 
is restricted according to the Term Sheet, as SARG maintains a right of first refusal on SARMC's 
interest. However, given the competitive nature of the industry and strong merger and 
acquisition activity, it could be reasonably anticipated that liquidity does exit for a 50 percent 
ownership interest in the Center as of the valuation date. 
The subject of whether or not a discount for lack of marketability should be applied to a 
controlling interest has been and is being debated among valuation experts.7 In our view, lack of 
marketability is less of an issue for a controlling interest than for a minority interest, primarily 
since a controlling shareholder can effect the sale of a company, cause dividends to be paid, or 
cause a repurchase of shares, all of which tends to compensate for lack of liquidity. However, 
even controlling interests in private companies can be less readily marketable than public 
companies. Reasons for this include difficulties in selling private companies and the 
unwillingness of private company owners to publicly auction their companies as is typically 
required by public companies. 
Although SARMC does not own a controlling interest in the Center, it does own a significant 
non-controlling interest. Its 50 percent interest allows it to greatly influence the strategic 
decisions concerning !MI, including the ability to, among others, select management, establish 
compensation and benefits, set corporate strategies, acquire or liquidate assets, and liquidate, sell 
or recapitalize the Center. Therefore, SARMC's 50 percent ownership interest in the Center 
possesses many of the characteristics of a controlling interest. 
According to an article published in the Business Valuation Review,8 Christopher Mercer 
suggests that there are two potential costs, transaction costs and taxes, that should be considered 
in the determination of an appropriate lack or marketability discount. Mercer suggests that 
transaction costs for smaller businesses can range from 10 percent or more, while for larger 
businesses, transaction cost would be much smaller as a percentage of value. He also assumes 
that taxes will always be paid by the selling shareholders. Depending on the market 
caphalization of the subject company, Mercer indicates that the appropriate lack of marketability 
discount for a controlling, non-marketable interest ranges from 3 to 20 percent. 
As the estimated market capitalization for Il\1I is $4.0 million, Mercer's guideline would suggest 
a lack of marketability discount in the range of 15 to 20 percent, assuming a controlling interest. 
However, SARMC does not have the control necessary to cause strategic decisions to be made, 
but does have control to suppress strategic decisions, all else being equal. While the 
combination of factors present in !MI as of the valuation date suggest the application of 
7Mercer, z. Christopher) "Should Marketability Discounts be Applied to Controlling Interests of Private 
Companies," Business Vaiua!lon Review, June 1994. 
8 Mercer, Z. Christopher. 
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discounts would likely be appropriate in this instance, we have considered the purpose of the 
valuation, the intent of the parties, and the operational versus investment interest in the Center. 
Evidence suggests that if the parties anticipated selling their interests, we might expect a 
discount for lack of marketability. However, given their intent to hold their investment as an 
operational investment with a community interest, we have not taken a discount in arriving at our 
conclusion. 
SUMMARY AND CONCLUSION 
As discussed above, we have estimated the fair market value of SARMC's 50 percent interest in 
!MI as of September 1, 1999 using the Asset Accumulation Approach. We have relied on the 
Asset Accumulation Approach due to the early stage nature of the business. In this instance, the 
Center's net asset (book) value is a reasonable proxy for fair market value as the Center 
commenced operations as of the valuation date. Thus, we have relied upon information supplied 
to us by SARMC concerning the Center's opening balance sheet and its net asset value in 
arriving at our estimate of fair market value, prior to consideration for any discounts for Jack of 
marketability. In light of the current industry conditions and the facts and circumstances 
surrounding SARMC's investment in the Center, we have not applied any discounts in this 
instance. 
Based on the analysis and considerations described in this report, we have estimated the fair 
market value of SARMC's 50 percent interest in Lv!I on a non-controlling interest basis to be 
approximately $622,000. 
Should yon require any additional information, please do not hesitate to contact Raina Dennison 
at (617) 478-9504, Allen D. Hahn at (617) 478-9018 or David A. Spieler at (617) 478-5057 in 
our Boston office. 
Very truly yours, 
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Exhibit I 
Opening Balance Sheet. as of September 1, 1999 
ASSETS 
Cash $550,000 
Fixed Assets $3,466,673 
Toial Assets $4,016,673 
LIABrLITIES 
Long: Term Loan $2,773,338 
Total Liabilities $2,773,338 
SHAREHOLDERS'EQUTfY 
C!!l2ital Contributed $1J43,334 
Total Equity $1,243,334 
Total Liabilities and Equity $4,016,673 
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Statement of Limiting Conditions 
The following Statement of Limiting Conditions applies to valuation services performed by 
PricewaterhouseCoopers LLP ("PwC"), 
Valuation reports may contain estimates of future financial performance, or opmions that 
represent management's view of reasonable expectations at a particular point in time, but such 
information., estimates, or opinions are not offered as predictions or as assurances that a 
particular level of income or profit will be achieved, that events will occur, or that a particular 
price will be offered or accepted. Actual results achieved during the period covered by the 
prospective financial analyses will vary from those described in our report, and the variations 
may be material. 
PwC does not, as part of these services, perform an audit, review, or examination ( as defined by 
the American Institute of Certified Public Accountants) of any of the historical or prospective 
financial information used, and therefore does not express any opinion with regard to same. 
Our procedures did not include investigation of, and we assume no responsibility for, the titles 
to, or any liens against lntermountain Imaging Center ("IMI" or "the Center"). Furthermore, we 
assume there are no hidden or unexpected conditions that could affect the value of IMI and 
accept no responsibility for discovering such conditions. 
None of our partners or employees who worked on this engagement has any known financial 
interest in the outcome of this valuation, Further, the compensation for this engagement is 
neither based nor contingent on the value determined. 
Neither the report nor any portions thereof ( especially any conclusions as to value, the identity of 
the appraisers or PwC, or any reference to recognized appraisal organizations or the designations 
they confer) shall be disseminated to the public through public relations media, news media, 
advertising media, sales media, or any other public means of communication without the prior 
written consent and approval of the appraisers and PwC. The date(s) of the valuation to which 
the value estimate conclusions apply is set forth in the letter of transmittal and within the body of 
the report. The value is based on the purchasing power of the United States dollar as of that date. 
In the absence of competent .teclmical advice to the contrary, it is assumed that Ilvfi is not 
adversely affected by concealed hazards such as, but not limited to asbestos, hazardous or 
contaminated substances, toxic waste, or radioactivity. 
No opinion is rendered as to property title, which is assumed to be good and marketable. Unless 
otherwise stated, no consideration is given to liens or encumbrances against the property. 
Sketches, maps, photos, or other graphic aids included in appraisal reports are intended to assist 
the reader in ready identification and visualization of the property, and are not intended for 
technical purposes. 
Tax positions taken by St. Alphonsus Regional Medical Center or IM!, which utilize the results 
of our work, are the responsibility of the taxpayer. 
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Restructuring of MRI Associates General Partnership 
Scenario 5 
SARMC withdraws from MR1 Associates to provide flexibility to form potentially 
competing ventures 
Considerations 
1) The Partnership Agreement restricts the ability of Hospital Partners to 
withdraw from MRI Associates. A Hospital Partner may withdraw at any 
time if, in the Hospital Partner's reasonable judgement, continued 
participation in MRI Associates: 
• jeopardizes the tax-exempt status of the Hospital Partner; 
• jeopardizes medicare/medicaid or insurance reimbursements or 
participations; 
• if the business activities of MRI Associates are contrary to the ethical 
principles of the Roman Catholic Church; or 
• is or may be in violation of any local, state or federal laws, rules or 
regulations (Articles of Partnership, Section 6.1) 
2) SARMC would be restricted for a period of one year after becoming a 
Terminated Partner from engaging in any Competitive Activity (Third 
Amendment to Articles of Pattnen:ltip, Section 8.1) 
3) A favorable vote of all current members of the Board of Partners can waive 
the Partnership's rights with respect to any particular activity and Restricted 
Party (Articles of Partnership, Section 9.4) 
4) The appearance of shifting referrals may potentially result in legal 
challenges from GP and LP interest holders, and investigations from State 
and Federal authorities 
5) Unless othenvise agreed, SARMC would receive the balance of its . 
Partner's capital account at the time of withdrawal (Articles· of Partnership, 
Section 6.1) 
6) Withdrawal would not relieve SARMC from any contingent liability in 
existence at the time of withdrawal (Articles of Partnership, Section 6.3) 
7) SARMC would retain limited partnership interests in Idaho and Mobile 
SARMC08062 
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The purpose of this letter is to tiocumcm the coopen1tfon between Saint Alphonsus 
Regional Medical Center, MRI Associates -and lnte:nnountaio Medical lmag:ing. Final 
ne;otiations are procccdillg between SA.RMC, MRJ and !Ml on SARMC and MRI 
becoming pllrt owners of the CT and MRI divisions rcspectivc:ly ofIMJ. Both SARMC 
o.nd MRI reviewed and !!)proved the JMI budget projections as part of this process1 
.,I,-. 'f.1- () I o,-1.,i M,··'·"'f ' 
The agreement between SAR.MC and IMI is an estimated 60 aays ouy SA~C h.a1/ 
already made a number of tangible investments illto IMI, including lie following;/ 
• SAR.MC provided its case volume, databe~, technical cvmponent cbarg~. staffing 
and supply costs, and other operational data for lMl reference in developing the lMI 
business i?lan. 
• Karen Noyes, assistant director of the SAR.MC radiology department, is joining tMI 
as ~Jc:,ecutive director. 
• SARMC programmers have interconnected the SAR.MC and !MI computers ro share 
demograt)hic and case management data between SAR.i\ifC and il\,fl. 
• SARM:C has linked Il\11 to its inttane1 betwt;en the nospiw and its physii;:lan a.etwork. 
th.e Ctinieia."l. De~ldcp system. 
" Subsequtn.t to.IMf conb':acting to purchase the DR Systems 4igitaJ radiology system, 
SAR.MC disco{lli!lue4 its r¢g-0tJatiotis w.iih another vendo, and also began working 
with DR Sy$t.em,, :w that $AR.\1C IUld IMl will be u:1i:ng lhc same IYJ» 1>fsystems. 
This ir1iails a s:ystem conversi<m and invi:::strnent of several humlred thousand dollars 
for SARMC. 
Thi:: Saint Alphonsus Radiology Group physicians have fot 2.5 years worked closely with 
· SAR.MC and cont:ra:cced with SAR?v!C to provide the pwfessional mc:dicill services for 
the rildiofogy dcpartm~t ;1t SARMC. This comract luls just been extended five years. In 
respect qf the SARMC cocpetation and intwded ownership poshion in !Ml, the 
radiologists rleditiM on jointly developing an imagitl.g center with the [daho Elks 
RdlabiJiJat~l)!'I Hospital. 
The agreeI)iel'lt between MIU and IMI is 60 or more, days ~ut. An 11PPntfaa.l fa being 
completed by Price Waterhoi.1$e, Boston. In regard to the MR1 affiliation with IMI, the 
following are noted; 
.. Mcmbc:B of me MRI AS!lociat:es hoard have wmmunicated their ful1 snppon· of the 
MRl OM!ershlp in 1M! and WI ownership in MRl, and committed their votes in 
fav~r of the cross 9wnership. 
• MRI has off~red fo.t IMI to lel!.Se employees from iIS pool of 40 experienced MRI 
technologists on an as needed basis. 
• The mllm1ging pam1er ofll\,fl is on rhe board of MRI A~soclates, and is highly 
regarded by both groups. 
• IMI and MRl share the same financial manager. PNtctice Management. lnc,. and Other 
key profossional rcsmJ.rce!.. 
1'h.e Saint Alphonius Radiology Group physicians ha.ve for many years provided the 
profossionai medical services for MRI c;:ise, ;it MRJ limited, and continue to do so. 
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MINUTES 
GROUP MEETING 
SEPTEMBER 8, 1999 
In attendance: Joe Gobel, David Giles, Paul Traughber, Vic Garabedian, Neil Davey, Ian Davey, 
Jeff Seabourn, John Knochel, Jeff Cliff, Paul DeWitt, Karen Noyes and Kathy Sharpe, Secretary. 
I IMAGING CENTER UPDATE 
A. 
B. 
Karen presented a site update (see attachment). The exterior on the north side is 
nearly complete and the signs should be ready on time. The interior finishing 
work is progressing with approximately 90% of the artwork having been hung. 
The referring physicians need to be reminded that they need to sign the order form 
in order to have the correct ICD-9 codes. 
C. When reading cases from the center, the case needs to be identified as to whether 
it is an Itv!I case or not. The patient's date of birth is currently being used as the 
medical record number. Karen requested that if a Radiologist takes an !MI case 
back to the hospital, that they let someone at the front desk know so that the case 
can be tracked. 
D. The problem with the MRI unit has been fixed. Toe RF shielding had a leak into 
the fire alarm RF filters. These have been sealed and everything is up and 
running well and the images look great. Dr. Seabourn would like to have the 
missed application time restored due to the magnet being down. Karen will check 
into this. 
E. Karen stated that the repaired Lumysis system as yet to be delivered. Current!;•, 
plain fihn~ cannot be taken without this system. Karen will check to see if DR 
has a Lumysis system with Dr loaded on it. Dr. Knochel motioned to forget the 
Lumysis and install the AGFA CR that is in storage and call DR to see how 
quickly they can supple a digitizer that is DR configured. Dr. Gobel seconded the 
motion and the motion passed. Karen will follow-up with DR. 
F. Karen presented an Emergency Medication and Treatment Protocol handout for 
review. Dr. Gobel stated that ACLS training can be done as a group in three 
sessions. Drs. Knochel and Ian Davey are already trained and certified and will 
cover the department during these training sessions. Dr. Gobel will set the first 
session up for Wednesday, September 15, 1999. 
G. Karen cautioned the Group not to promise too much to referring physicians, as the 
center will need to continue to meet the standards of practice and protocols. Dr. 
Seaboum would like to see what screening questions other offices are currently 
asking patients and see if this can be streamlined. 
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DATE: 
TrME: 
P!,ACE: 
August 14, 200 l 
5:30 p.m. 
Pioneer Room 
PRESENT: EXCUSED: 
Jeff Cliff 
Tim Hall, MD 
JeffSeaboum, MD 
Neil Davey, MD 
Joe Gobel, MD 
Karen Noyes 
RECORDER: 
Karen Noyes 
Ken Fry 
Mike Ondracek 
Leslie Kelly Hall 
Scott Christensen 
I. ASSIGNilfENTS 
Decision made that Dr. Seabourn would be the IM! Chair, and Ken Fry would 
be the SAR.i\1C Vice Chair. 
Jeff Cliff will be delegated responsibility of !CR Chair. For Executive 
sessions, the Chair will decide if Jeff Ciiff should chair that portion of the 
board meeting. 
,lotion Motion made to modify the operating agreement to include four members 
as representatives from ICR and SAJtMC instead of three. Motion 
approved unanimously. 
II. PHYSICIAN REFERRAL PATTERN 
See attached graphs on physician referral patterns and SARJVlC/fMf split on 
referring physicians. 
Discussed information regarding SL Luke's opening an outpatient lmaging 
Center with PACS system. 
lMl West update with timeline of May 2002 opening. Cherry Lane target of 
October 2002. 
1 
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IV. 
Motion 
In order to complete the operating agrec111e\1t the hoartl needs to execute a 
Medical Director Agreement, and Service Level Agreement. 
Mike Ondracek will provide Jeff Cliff with some examples of Medical 
Director agreements for review by !CR. 
Leslie Kelly-Hal! wi!I prepare a service level agreement for review by the 
board. 
FEE'S & FINANCE 
!Mf is covering any negative cash balances in the non-MRI component with 
cash from the MRJ component. Board agreed unanimously lo charge interest 
monthly, at the same rate as our line-of-credit with U.S. Bank on the negative 
cash balance. 
Jeff Cliff presented the current financial statements: 
Jeff Cliff reported that the Group bas bee11 approved for financing oUMI 
West. Dr. Seabourn conveyed a message from US Bank Account VP that 
things are looking good; ratio benchmarks are being surpassed when 
looking at !Ml as a whole. 
PET Billing discussion 
Owned by !Ml; parked at SARMC. 
Medicare in-patients must be billed under A PC schedule. 
When coach is at !Ml West, must bill under the physician fee schedule. 
Motion made to have St. Als "lease" PET from IMI and bill Medicare 
patients under APC schedule. Approved unanimously. 
SUBCOMITTEE: Mike Ondracek, Ken Fry, and Jeff Cliff will work on 
the contract for the· lease agreement, reimbursement, etc for Nledicare. 
V. MARKETING 
Dr. Neil Davey presented an overview of the history and devclopmenl of 
!Nll's marketing plan. 
Background: 
Marketing consultant hired. 
Continued sponsorship of the Shakespeare Festival. 
Focusing on non-MRI compone11t 
Medical education event slated form October 6"' at Grove Hotel 
August [3 th - Dr. Ed Coleman - Dinner/lecture/educational event. PET 
expert from Duke University will do Grand Rounds at S/\RMC. 
Physician office visits to continue and upgraded for PET. 
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Web Page - Vendor selection in progress. Go live date of October 2001. 
Leslie offered many "tip;:;" when working with marketing web site 
vendors, etc. She has also offered her assistance in whatever level rMI 
would like. The marketing commiltee will review RFP's from web page 
vendors. 
Have seen results in the growth of the no11~!\.'1Rl numbers in the last 18 
months of marketing 
OPERATIONS 
Focw, un DR and connectivity. Emphasize contribution of.tnformation 
Resources a:; a key component of our success. Need IR to be adeqlialely 
staffed and funded to grow! 
Concern with DR Communicator - Web Base product and not being 
"live" after 18 months of operation at IML Leslie reports dark fiber is all 
in place ($780,000 investment by SARMC) to IMI West, Cherry Lane, 
and Caldwell for connectivity. 
DR-Communicator Button 
• Firewall completed 
• Internet pipe increased by 70% 
• Security verified 
• Programming done 
• DR is working to re-archite~t port site to 
aUow connection to internet/SAR.MC. 
Unknown collJ.pletion date. 
Outstandinu DR Issue 
• Multi-entity connectivity - not available yet 
by DR. Slated for November 2001. This 
will allow viewer to mix all entities together 
(SARMC, lMI, MRJCI) or to view 
independently /separately. 
Laptops - DR 
• Exist at about 20 sites now 
• Having difficulty getting written "feedback" 
from physician offices, but good verbal 
feedback 
ACTION: Leslie to present a report on the following at each meeting: 
• Physician feedback - DR- response 
• Report specific to rtvfI or ca11s, response time, etc 
" DR communicator update from SARMC/DR 
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Vll. PET Site 
Cindy Schamp has met 'with the MRJCI gronp and dis{:t:ssed oLu- use of the 
current MRJ ?,foblle pad at SAl<-vfC. MRJ is okay wi:h sharing the use of 
the pad. 
ACTION: JeffClifflo contact Cindy Schamp to ask MRlC: if!MI can 
share the semi to pull cur PET off the pad and park it in the RV parking 
lot behind Liberty when they need to utilize t:J.e pad. 
Vlll NEXT MEETING 
Adriana to organize ar. [R committee to work on !MI Wesl uoru,ectivity. 
Meetings will be held once a month for the next six month_s at 6:00 a.rn. Jeff 
CHff to schedule next meetings. 
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MARKF,TfNG COMMITTEE 
MlN1JT!tS 
DATE: November 28, 2001 
12:00 p.m. TIME: 
PLACE: Radiology Conference Room 
!'RESENT: EXCUSED: 
Neil Davey, MD 
lan Davey, :,.,ID 
Joe Gobel, MD 
Jeff Cliff 
Rachel Bergmann 
Tim Hall, MD 
Karen Noyes 
RF,CORDER: 
N:cole r ,indauer 
I. LUNG CANCER SCREENING 
Kim Carley to contact Dr. Neil Davey regarding presentation on channel 2. 
II. IMJ/SARMC MARKETI!VG 
Ken Fry is making arrangements to have one of SARl'vlC's marketing 
members present at !Ml Marketing meetings. The committee to look at 
splitting !Ml marketing and SARMC marketing into two meetings. 
Continue to keep !Ml brand name in the public tn bring in business that we do 
not cuncntly have at SARMC. SARMC and !MI to work towards a combined 
market share. lflMI is full, will transfer patients to SARMC and vise versa. 
III. REFERRAL NWl!lBERS 
Rachel Bergmann broke out information on each of the events and how the 
referral numbers looked prior to and after. Sec attached. 
Shakespeare - Use as a fundraising venue for Shakespeare. 
CME ·- Did i101 change where physicians 8ent their patients 1 wiU need to 
reevaluate. 
IV. DR STRATEGIC PLANNING 
Current PACS Committee consists of Raebel Bergmann, Karen Noyes, Chris 
Hayden, Leslie Kelly-Hall, Mark Wenstrom, Scott Christensen, Terry 
Krogstad, Dr. Seabourn and occa.sionally Drn. Knochel and Scales. Continue 
to make sure Drs. Seabourn and Scales working on same page as Marketing 
Committee. 
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Quarterly evaluations on volumes are compared to SARMC, lMI and MRJCI, 
having each pay their share for the rnllout. 
Leslie Kelly-Hall working on getting more support staff to begin office 
follow-,:.p, Key to success is backup service and follow-up. 
The Web Ambassador will not be available over the Internet. Will be usii:g 
direct Ambassador software: which has a more secure connection. Alrea<ly 
have the Ambassador software, just need to distribute it. Holdup ls staff, a1.1d 
may have proble:iis with connectivity due to need for brmidband. 
Drs. Neil and Ian Davey tc look at marketing to the Djernes Group in Nampa. 
Rachel Bergmann to contact. 
NHVSLETTER 
Dr. Scales has made some changes. After chsnges made, Rachel will bring 
the proof back to Dr. Neil Davey to sign off 
VI. WEBSITE 
Rachel discussed the maintenance plan with Wirestone. Rachel wiil continue 
to batch changes or additions for Wirestone to maintain. The Radiologist,:; 
need to get an image library set up> not only to include images of:' of each 
modality, but logos, maps, picture of the buildings, etc. Changes to occur 
quarterly. 
Wirestone may be able to put in tracking capability to see areas where the site 
is getting the most hits. 
YN orking on having the newsletter on archive. 
VII. PET 
Discussion of Dr. Sawyer pkk:ng days for patients to be scanned. Drs. Neil 
and !an Davey to revisit Dr. Sa"yer. 
Ors. Neil and Ian Davey and Rachel to meet with Pub1onologists. CmTently 
only getting referrals from Dr. Crowl.ey. 
Blue shield, not participating in the reading (professional component). Worth 
accepting what's allowable from Blue Shield on the PC lo help generate 
business on the TC. Jeff Cliff to discuss with PM!. 
Requisitlons coming steadily. \Vith recurrent bre8st cancer and tracking of 
treatrnent, numbers should incrett<;e. 
Da(c: 
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CME 
36 Physician and Med!cal ?roviders attended 
•• Average monthly referral of 152 for the 3 months prier to 1he CME 
.. 114 referrals noted for the Month of October, will continue to monitor for the next coup!e of :r,onths. 
Shakespeare 
27 Phys!cans and Medical Providers RSVP'd 
.. Average monthJy referral of 243 for the 3 months prior \a Shakespeare 
·~Average monthly referral of 214 for the 3 months after August 4th 
DR 
Communicator 
26 Physicians and Medlcal Providers have sccess to Communicator since September 
··Average monthly referral of 134 for the 8 -nonths prior to Communicator being available 
••Average mcn!h!y referral of 110 a month :'or the last 2 months after Communicator has been available, will continue to :nor.fair 
Communicator/Pilot 
7 Physicians have both the Communicator and Wireless laptops avallable to !hem 
'•Average monthly referral of 49 for the 2 months prior lo pilot install 
··Average monthly referral of 35 for the month after the f:):lot Install 
·•Average monthly referral of 33 after the Communicator was availabfe 
Wireless Pi/of 
68 Physicians and Medical Providers :"lave access to a Wireless laptop 
-Average montflly referral of 526 for the 2 months pfior to the pilot installs 
"'Average monthly referral of 578 •or the 7 months after the pilot installs 
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IMI l'YIARKETING COM.,v!ITTEE REPORT 
NOVEMBER 2001 
CURREm' PROJECTS : 
NEWSLETTER : 
January distribution 
Lead articles-lMI West, Women's imaging 
!MI West - Architectural illustration 
- Floor plan 
- Site photo 
Worr:en's imaging - role of MRI in cervical cancer 
Biographies of the three new IMJ Radiologists 
Draft of second edition to authors 
WEBSITE: 
CME: 
Now online - www.idahoxray.com or www.aboutimi.com 
Updated quarterly 
Currently twenty video recordings distributed (l Oto physicians) 
FUTURE PRO,ffiCTS : 
IMI WEST: 
Ongoing marketing efforts - Newsletter and website 
New marketing efforts- MD to MD office visits (Meridian zip codes) 
Press : Newspaper, TV, Radio (NPR) 
Open house 
IDAHO SHAKESPEARE FESTIVAL : 
Host the opening night of sponsored play 
Six tickets per play - distributed to staff 
4 
Confidential 
GSRRP/000664 
EXHIBITG 
EXHIBIT G 
0UTPAT1fNT 
RAOIOLOGY CENTER 
Computed iomogranny 
Ul!rasoMgraphy 
Uona Oonsity Scanning 
Mammography 
fluurost!ljl'/ 
BOAl)O CERTIFIED 
ll:flDIOLOGfSTS 
Rica(do R. Aballo, M.0. 
1ai1 C. Davey, M.D, 
Nail C. Davey, M.O, 
Vick Gmabedian. M.O, 
oe~id Gile;, M.O. 
R. Jose~h Gebel. M.0 
J.T. Hall. M.O. 
John 0. t<r-oche!. M,D. 
Wi!Hom T. Murrnv, M.O. 
Oiafie R. Newton. M.D. 
Jeffrey T. Seabourn. M.O. 
Uso M. Scales. M.O, 
Paul TraugnllM, M,O 
DIRECTOR OF 
MEDICAL 1MAGING 
Karen Nuv~. B.S .. IU.. iRIICl) 
Confidential 
October 4, 1999 
VICKEN GARABEDIAN, MD 
1055 N CURTIS RD 
BOISE, ID 83706-1352 
RE: Opening of lntermountain Medical Imaging Outpatient Radiology 
Center 
Dear Dr. GARABEDIAN 
We are proud to announce the opening of lntermountain Medical Imaging. 
This brand new state-of-the-art facility is the first full service outpatienl 
radiology center in the Treasure Valley. As a physician group, we have 
always been committed to providing high quality service to our valued 
clinical colleagues. Additionally, we also pride ourselves in staying on lhe 
technological cutting edge of diagnostic imaging. In that 1radition, we are 
making a paradigm shift away from our current filrr\-bai;ed system to a 
filmless image management sys1em, We will be using G<Jmputers to 
display, archive, 1ransmii, and. restore images at our facility, This process 
will include all digital imaging modalities: MRI, CT, US, standard x-rays, 
fluorosccpy, and special procedures. Mammography will ccntinue to utilize 
a ftlm-based medium for the foreseeable future. 
This change will have several benefits for you and your patients: 
> Lost reccrds will be eliminated-all images will be permanently 
archived in a digilal format on CD ROM or DVD discs. 
> Images and reports will be available more promptly. 
> A paper image "montage" of the Radiologist's key selected 
images will be mailed with a final typewritten report sized for your 
patients' charts. 
> Access to subspecialty Radiologists will be improved. 
> When fully implemented, you will be able 1o access images and 
audio report summaries via computer at remote locations such as 
the O.R. or in your office. We will be scheduling office visits to 
evaluate your current computer infrastructure so that we may 
determine the most effective way to transmit data to you. 
> Hazardous waste associated with traditional film and chemicals 
will be eliminated. 
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OUTPATIENT 
f\AOtolOGY CENTEil: 
Magneiic f\esonance 
Compwm Tomoqrnphy 
80110 Oensrtv Scannlnu 
'Jascolar /I n1erve111ional 
General Rarl1o!ogy 
BOAR() CERTIRED 
RAOIOLOG!STS 
Rirnrdo R, i\bello, M,O. 
Ian C, Davey, M.O. 
Nail C. oa~ov, M.O. 
Vid Garabedian, M,O. 
David Giles, M.0. 
A. Joseph Gobel, M.O. 
J.1. !!nit, M.O. 
John 0. Knochn!, M.O. 
William T. Mil/ray. M.O 
Oiane ~- Newton. M.D. 
Jeffrey T. Seabourn, M,O. 
lisa M. Stales. M.O. 
Paul T1aughhet M.O 
OlRECT.OR OF 
MEDICAL IMAGING 
Confidential 
During the upcoming implementation, our staff will be trained to use this 
new system. Although we are working diligently to ensure a smooth 
transition, we anticipate some growing pains. Our goal is to improve upon 
your current level of service. So, please let us know immediately if you are 
inconvenienced in any way. 
Many physicians are accustomed to receiving copies of film to review in 
their offices, Our long-term goal is to eliminate film completely, but we will 
maintain the capability to produce film copies of exams as well. We would 
appreciate you trying our new system which, when fully implemented, will 
improve access to images and reports. 
You may review imaging studies performed at lnterrnountain Medical 
Imaging from an Ambassador computer monitor in the St. Alphonsus file 
room. The simple program takes less than five minutes to learn. We are 
available to provide orientation at your convenience. 
Enclosed please find an informational brochure on our facilily as well as an 
order pad. If you are unfamiliar with our group of Radiologists or are 
interested. in. more detailed information, we invite you to visit our website at: 
www.idahdxray.com. 
We invite your feedback and open discussion. We look forward to selVing 
your medical imaging needs. 
Warm regards, 
Your Colleagues at lntermountain Medical Imaging 
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EXHIBITH 
EXHIBIT H 
January 4, 2000 
Sandi a Bruce 
President and CEO 
Saint Alphonsus Regional Medical Center, Inc. 
1055 N. Curtis Road 
Boise, ldaho 83706 
Dear 3andra, 
Dr. Curran and I have reviewed with the other members of Doctors Corp our 
imprc ssions of the meeting we attended with you and the radiologists on December l 6, 1999. 
This letter is intended to communicate our feelings on thal meeting subsequent to discussions 
within Doctors Corp. 
It is the opinion of Doctor's Corp that a win-win, coop,,rative so.lution lo the 
prob I om must be found and will require the strong use of your influence as CEO of SARMC. 
Most of the demands of the radiologists could be accomplished over Lme. The following general 
fonrn l could be made to work. 
I. Three General Partnership positions could be rr,ade available for SARMC, 
MRl Associates or the hospital partners to purchase. These could be held 
or resold to the radiologists. Two General Partnership positions would 
come from Drs. Giles and Henson and. the third would be newly created. 
2. Ors. Curran, Havlina, and Prochaska are not currently willing sellers but 
would listen to offers. They have all agreed co.1ceptually to create an 
agreement whereby they would be bought out at specific times according 
to some mutually agreeable evaluation 111echan°.s111(s) or fonnula(s). The 
Hospitals might have to establish rights of refusal and pnssihly commit 
some of these lo the radiologists. 
3. The suggestion by the radiologists to split the two companies is not 
considered appropriate or desirable at this time It would have to be 
acceptable to all the hospital pat1ners and the rr.ajority of Doctors Corp. 
The concerns expressed at the meeting regarding the problems of not having a 
scam ess department would be present regardless of who the owners fare. Any solutions available 
to th, radiologists as one of multiple partners could be incorporated under the present ownership. 
Any 1alid concerns need to be addressed immediately and are independent of ownership. 
SARMC00640 
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Sand ··a Bruce 
Janu:,ry 4, 2000 
Page 2 
The lime has 0on1<:: for SARMC to insist on and provicie full, supportive 
radio logic coverage of the lab at historical levels of professionalism and service. These standards 
are c ear nationally and in the SAfu'v!C radiology department. Along with the professional 
inte17'retation and supervision of the lab comes the obligation to notify the lab/hospital of all 
de!ic encies and safety concerns and to make professional recommendations as to departmental 
need<, including new equipment and upgrades required to maintain the state of the art. This 
comr 1itment is integral to all radiology professional contracts including the SARMC main 
depa, tment. It cannot be allowed to. be withdrawn simply because th, radiologists of the I.ab are 
now .,!so its competitors. The highest standard of care for patients is ·essential and includes 
havir g radiologists on site to supervise studies as needed. We now view as a necessity 
SAR v!C's providing the lab with full, supportive, traditional radiologist coverage or pennitting 
tbe l'v RJ Center of Idaho to contract directly with radiologists as a fi<l1ciary responsibility of 
SAR:v!C Lo its other general and limited partners. We also see it as our responsibility Lo point 
tbis cul. 
The MRl partnership has been a model of cooperative networking among multiple 
hospitals and physicians. This has been accomplished by treating ent;ties fairly and by 
committing Lo a win-win approach to networking and problem resolution. The current position 
of th, SARMC contract radiologists creates a real challenge to continuing this tradition. It is not 
too late lo create a mutually workable and beneficial solution. The MRJ Cente:r of Idaho has 
estab isbed an exemplary and extraordinary, patient-oriented service whose commitment lo 
excel enee has spread to the mobile operation and bas benefited quality patient care tbroughoul 
ihe N )Jihwest. SARMC made the decision lo provide MRI services t:irougb the mechanism of 
tbi.s p1rtnership. Your support for the commitments ofSARMC to this partnership will be 
clearly needed to resolve the current impasse. 
Sincerely, 
i:;,?_a ·/ ~~ /-v 
, /Z>-· ,.--;._~~ ~ ... 
'-..~, .. / 
James Prochaska, M.D., for Doctors Corp 
SARMC00641 
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EXHIBIT I 
EXHIBIT I 
Gem State 1/'] 
Radioll)gy 877 W Ma!n Street. Suite 603 • 3oisl!, lda:lo 8'.57C2 • tel 208.384.9060 • i'ax 208.J<M.9023 
B0A.!W CliRW'lt:0 
RA!llOLOG!STS 
carolyn Coffman, M.D. 
cunts H. coulam, M.D. 
lan C. Davey, M.D. 
Nell C. Davey, !\ILO. 
Vick Garabedian, M.D. 
R. Joseph Gobel, M.O. 
j.1: Hal!, M.D. 
John Q. Knoche!, M.D. 
Wi!liam T. Murrny, M.D. 
Oa!lus O. Peck, M.0, 
Mkhacl J. Ryan, M.D, 
Jeffrey T. Seabourn, M.D. 
Usa M. scales, M.D. 
Paul Traughber, M.D. 
l!XECUT!V!~ DlltECTOlt 
Jeffrey R. C!!ff 
August 7, 2002 
To: MRJ Center of Idaho Scheduling Department, Radiology Scheduling Department 
From: Radiologists 
Re: Scheduling. 
There has been a "mission creep" with respect to the scheduling of cases requiring the 
administration of intravenous contrast material, and the scheduling of 'after~hours monitored 
cases'. In addition, triticaJly i!J St Alphonsus house patients are ofl:en being examined during 
the late night hours. 
We are concerned with this process, and want to reiterate that it cannot be assumed that we are 
'immediately available' for care ln the case of a contrast reaction, or to provide physiC!an 
monitoring, for the complicated patients being electively screened after hours. We are asking 
that a!l contrast cases after hours be restricted to 'emergent basis' only. House cases requiring~ 
nursing care, and physician mo11itoring be performed. during normal working hours. Add on 
elective cases requiring physician l11pu:t should appropriately be scheduled at times that we can 
realistically be expected to be available. (Monday to Friday, 0700-1900). All cases that fall 
outside of this time frame, (other than routine, non-monitored cases), need to be specifically 
approved by the On~cal! Radiologist as an emerri;ent add-on. 
Thank you for your time and consideration in this matter. 
We will expect implementation of this policy by 8/!9/2002. 
Sincerely, 
Jilt-
1 
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EXHIBIT J 
Date: 
Present: 
Gnests: 
Absent: 
Recording: 
Confidential 
MRI of Idaho Special Meeting 
September 8, 2003 
Roger Curran, M.D. Chairman 
Thomas Henson, M.D. 
James Prochaska, M.D 
Sandra Bruce, CEO SARMC 
Ken Fry, CFO, SARMC 
Mark Dalley, CEO Holy Rosary Med. Ctr. 
Mark Adams, CEO, West Valley Medical Center, Caldwell. 
Joseph Messmer, CEO Mercy Medical Center 
Randy Hudspeth, Dir. Professional Practice SAR.MC 
Rick Presnell, Chief Accounting Officer, SAR.lvfC 
Jack Floyd, CEO MRICI/MRl Mobile 
Dr. Scott Henson 
Michael Cacchillo, Dir, Bus. Dev. MRICI/MRIM 
Kevin West, Gen. Counsel MRI CI 
Patrick Miller, SAR.MC Counsel 
Stephanie Westermeier, SARMC Counsel 
David Giles, M.D .. Medical Director 
Jack Havlina, M.D 
Andrew Fitzgerald, CFO Holy Rosary Med.Ctr 
Michael Cacchillo 
Chairman, Roger Curran opened the special session at 5:09pm, 
welcoming Sandra Bruce, Ken Fry and the SAR.MC Counsels as 
well as Kevin West, MRJ Gen. Couruiel to the meeting .. With the 
Radiology agreement discussion as the primary item, Dr. Curran 
recognized Sandra Bruce and asked that she share the St. 
Alphonsus Regional Medical Center perspective on the proposed 
agreement and her positions, insights etc. Sandra produced a single 
page agenda (see enclosed document) aimed at addressing the 
current MRI Service Agreement and a discussion of the Long 
Tenn Relationship Issues. She then gave an overview of services 
provided by the radiologists to St. Alphonsus. Ms. Bruce 
acknowledged the Radiologists time cutback to l 2 hours per day, 
(5) five days per week with emergency coverage. The board 
brought up the fact that the proposed agreement was for hospital 
inpatients and hospital outpatients and the Radiologists were not 
doing off-hour coverage. This meant that 85% of the volume of 
Page 3 10/13/2003 
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MRJCI was not being addressed directly. Additionally, after hours 
Radiologists were not always receptive to handling emergencies. 
Ms. Brnce requested data with patient names and days of 
occurrences to allow her to address the rads with the issues. 
The board indicated that infonnation was being disseminated that 
would have local physicians believe that Gem State Radiology/[Ml 
owned the DR system and could dictate exclusivity of what goes 
on the system and who reads scans. Ms, Bruce said she was 
unaware of the issues and suggested that a committee be formed of 
representatives from both St. Al's and MRI CI to address the issues, 
Initial names from St. Al's would be Ken Fry, Carolyn Corbett, Pat 
Miller and one person from IT. These individuals would be joined 
by individuals representing MRI of Idaho. 
A discussion ensued on the relationship of the Radiologists, 
technologists and misinformation that was being propagated in the 
Treasure Valley. (Jack Floyd or Board) sited five items of concern: 
l. General review of protocols by Rads as the technology has 
moved forward but the Radiologists haven't reviewed 
capabilities and protocols with the technologists to update 
2. Mentoring of the technologists with feedback from the 
Radiologists no longer happens, especially to address concerns 
by referring physicians 
3. The Radiologists periodically express quality concerns 
regarding MRlCl systems and coils, but do not document them 
for follow-up. In one case, MRI invited and secured a visit by a 
GE Vice President to address the purported issues but no one 
from GSR came to meet with him 
4. Statements of MRICI software being antiquated in light of 
purchase and installation of the latest Excite and Quantum 
software systems have not been dispelled 
5. Alleged technology of MRICI Systems not compatible with 
DR because of inadequate software configuration 
Sandra suggested that the issues sited actually lead to the second 
item on the agenda, that of on-going Long-term relationship issues. 
She stated that she felt the Relationship of MRl of Idaho and St. 
A!phonsus no longer worked. She saw the future as an integration 
effort with her medical staff and physician ownership the direction 
that St. Al's was beading. She felt that the best resolution would be 
a St. Al's buy-out of the MRI ofidaho business. At this statement, 
Sandra produced a document (see enclosure) that she had put 
together indicating a suggested timeline for the buyback 
negotiation and valuation process and stated if the transaction did 
not occur in a timely fashion that one of St. Al's options under the 
current agreement would be withdrawal from the partnership. She 
Page4 J0/13/2003 
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Jack Floyd, CEO 
MRJCI/MRI Mobile 
stated that Ken Fry would lead the negotiations for St Alphonsus 
and asked that someone from MRI of Idaho be appointed ro 
represent itself It was mutually agreed that the Board needed to 
caucus to review the proposal and to select a team to represent the 
Center. The special.session was brought to a close at 5:39pm and 
followed immediately by an abbreviated September Board 
Meeting See September Board Meeting Minutes 
l Roger Curran, M,D Chairman, 
MRJCI/MRl Mobile 
Confidential Page 5 l0/13/2003 
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MRI of Idaho Special Meeting 
September 8, 2003 
5:00 p.m. to 7:00 p.m. 
Sister Patricia Room 
ATTENDEES: Andy Fitzgerald; David Giles, MD; Jack Floyd; Jack Havlina, MD; James Prochaska., MD; Joe Messmer, 
Mark Adams; Mark Dalley; Mike Cacchillo; Roger Curran, MD; S. Henson, MD; Thomas Henson, MD; 
Randy Hudspeth; Richard Presnell, 
GUESTS: Kevin West, Patrick Miller, Stephanie Westermeier. Ken Fry, Sandra Bruce 
1. MRl Service Agreement 
2. Long Term Relationship Issues 
10 Minutes NI A Discussion Appoint negotiation team to 
45 Minutes NIA 
resolve issues and set timeline for 
resolution. 
Discussion Agreement on next steps. 
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EXHIBIT K 
From: Scott Christensen 
To: 
Asstistants; 
Date: 
BCC; CT; Front Office; Gen Rad Techs; Nuc Med Group; Nurses; Rad Admin; Rad 
Specials; Ultrasound 
12112/05 8:44AM 
Subject: Fwd: New MRI Service 
FYI 
Scott E. Christensen B.S., R.T.(R) 
Manager, Radiology and Medical Imaging 
Saint Alphonsus R.M.C. 
Boise. Idaho 83706 
Telephone: (208)-367-6546 
FAX: (208)-367-2989 
e-mail: scotchri@SARMC.org 
»> Ben Murray 12/11/05 07:48AM »> 
Please see the attached memo and post for all staff - on the new Saint Alphonsus MRI service !hat begins 
on Monday, December 19th. More information will be distributed thru the next week. 
Also review an earlier email on !nservice programs related t the new monitors and pumps we have 
purchased for use In the new MRI. 
Ben Murray, RN 
Director of Nursing 
367-6234 (Office) 
855-6908 (Beeper) 
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DEPARTMENT OF RADIOLOGY 
@saintAlphonsus I INTER OFFICE MEMORANDUM 
To: 
From: 
Re: 
Date: 
Nurse Managers; All Nursing Staff 
Ben Murray, RN, MSN, Director of Nursing 
New MRI Operations Update 
December 11, 2005 
.....•................................•.......•.......................... 
As many of you are already aware, a new MRI service is beginning operations on 
campus on Monday December 19th • As of that date, Saint Alphonsus MRI will 
be the sole provider of MRI services for all Saint Alphonsus inpatient, 
outpatient and ED patients. The Mobile MRI will be located at door S6 near 
Endoscopy and Preadmission testing. A permanent MRI site is being constructed 
off the old mafn lobby, by the former cashiers office, and is expected to be 
completed in the Fall of 2006. The same fundamental procedures that have 
always been followed when utilizing MRI services will continue. There are a 
number of key points that are important for all staff to be aware of: 
1) MRI of Idaho will remain on campus as they have a long term lease on their 
current space. They will continue to serve non Alphonsus outpatients, but as 
of December 19'", they will no longer provide services to Saint 
Alphonsus connected patients. 
2) Gem State Radiology will continue to be responsible for the interpretation of 
all MRI studies and Saint Alphonsus will partner with lntermountain Medical 
Imaging in operating the new MRI service. 
3) To contact the Mobile MRI regarding ED and inpatients, staff should call 3340 
(as of December 19th). Further information about scheduling and contacting 
the Mobile MRI will be prominently posted in all areas in the next few days. 
When you enter STARS to process orders, the option that appears will be 
Saint Alphonsus MRI. 
4) Equipment - MRI compatible wheelchairs and gurneys have been purchased 
and will be used for transporting patients. We also have MRI compatible 
monitors and pumps - see related email of today re. education about the new 
equipment. 
5) Code Response - The Mobile unit is equipped with an emergency code 
response button. If there is a code in the Mobile unit, the code team will 
respond as usual. The Switchboard will overhead page - "Code Blue, Saint 
Alphonsus MRI, Door S6". At this time we will continue to provide code 
response for patients in the MRI of Idaho suite. If the switchboard pages a 
"Code Blue - MRI Center of Idaho", the code response team should 
respond as they always have. All ED and critical care nursing staff will be 
ATTORNEYS' EYES 
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able to access the MRI unit using their hospital ID; proximity to the magnet 
will not harm the ID badge. 
6) Transport • As per usual, monitored patients will be accompanied by a nurse, 
who will remain with the patient throughout the procedure. Pediatric patients 
will be accompanied under the standard terms of security for pediatric 
patients. If there are any delays at the point of service for critical care 
patients, they can be housed in the Ambulatory Surgery Center until final 
clearance to enter the MRI unit has been obtained. 
7) Anesthesia - During the occasional anesthesia procedures that take 
place in MRI, a Saint Alphonsus nurse will accompany and remain with 
the patient throughout the procedure. This can be the critical care or ED 
nurse who is always present anyway, the Radiology staff nurses or other 
nurses who have been trained in conscious sedation support. MRI staff will 
coordinate with the unit and the clinical coordinators to arrange the necessary 
and appropriate nursing support for non critical care patients. 
8) Facility - The Mobile MRI will have a sheltered canopy/ walkway, with 
heat and lights, so that patients do not have to go "outside" to enter the unit. 
The side of the Mobile has a garage door type opening and a lift to bring 
wheelchair and gurney bound patients into the control room. 
9) Safety - The same basic safety issues apply, as always, when in proximity to 
the magnet unit including: staff do not enter the magnet rdom itself unless 
they have specific clearance from the tech on duty; everyone needs to be 
mindful of metal objects such a name tag clips, pens, coins and so on; staff 
should make the MRI techs aware of your own history of pacemaker 
presence and other issues of possible embedded metal; follow all 
Instructions of the tech in regards to safety concerns (see MRI policy 
on line). Further in service education opportunities will be announced soon. 
10) Outpatients - All Saint Alphonsus MRI outpatients will be directed to enter 
thru door S2. They will sign in at Registration and be escorted or directed to 
the Radiology reception desk. Please assist any visitor who may be searching 
for either Saint Alphonsus MRI or the MRI of Idaho office. 
11 )More information will be forwarded to managers and staff in corning 
days - please make sure al such announcements are posted in the units for 
all staff to see. 
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